UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

 

þ

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended: December 31, 2014


OR

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from: _____________ to _____________

 

Commission file number: 000-54129

 

FONA, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

26-4369698

(State or Other Jurisdiction

(I.R.S. Employer

of Incorporation or Organization)

Identification No.)


1026 Anaconda Drive, Castle Rock, CO 80108

(Address of Principal Executive Offices)

  

  

Registrant’s telephone number, including area code: (303) 513-3510

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $.001 par value

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  o    No  þ


Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes  o    No  þ


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ    No  o


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  þ    No  o


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   þ


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.

 

Large accelerated filer

o

Accelerated filer

o

Non-accelerated filer

o

Smaller reporting company

þ

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    þ  Yes    o  No


The aggregate market value of common stock held by non-affiliates of the Registrant as of December 31, 2014 was $352,924 based on the closing price on the last day of trading prior to December 31, 2014.


Shares outstanding as of December 31, 2014 was 7,894,111 shares of common stock, $.001 par value.


DOCUMENTS INCORPORATED BY REFERENCE:   None

 

 




 


Cautionary Statement Regarding Forward-Looking Information


This report includes “forward-looking statements” that are subject to risks, uncertainties and other factors, including the risk that the Mergers will not be consummated, as the Mergers are subject to certain closing conditions.  All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including statements regarding the expected timing of the completion of the mergers and to complete the mergers considering the various closing conditions; continued compliance with government regulations, changing legislation or regulatory environments; any statements of expectation or belief and any statements of assumptions underlying any of the foregoing. These risks, uncertainties and other factors, and the general risks associated with the businesses of the Company described in the reports and other documents filed with the SEC, could cause actual results to differ materially from those referred to in the forward-looking statements.  The Company cautions readers not to rely on these forward-looking statements.  All forward-looking statements are based on information currently available to the Company and are qualified in their entirety by this cautionary statement.  The Company anticipates that subsequent events and developments may cause its views to change.  The information contained in this report speaks as of the date hereof and the Company has or undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise unless required by law.



PART I


ITEM 1. BUSINESS


Fona, Inc. (the "registrant" or "Company") was incorporated under the laws of the state of Minnesota in November 1990 under the name Fonahome Corporation. On March 24, 2009, the Company reincorporated in the state of Nevada and merged with its wholly-owned subsidiary, Fona, Inc., adopting the surviving company’s name, Fona, Inc. The Company was originally formed to develop and market an interactive information and advertising service.


Since December 1999, the Company has had no significant business operations other than licensing its internet-based Rent411 services to Desfaire, Inc. a company controlled by Nick T. Boosalis, a former officer and director of the Company. During the nine-year period ended December 31, 2007, the Company’s aggregate revenues were approximately $409,000 consisting of license fees paid by Desfaire, Inc. and its aggregate operating losses were approximately $200,000. Approximately $454,000 of the Company’s expenses during the nine-year period related to fees paid to third parties to provide the Rent411 services.


The Company has opted to become a "blank check" company and to further engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions.


On March 3, 2009, the Company held a shareholder meeting approving the Stock Purchase Agreement and an Agreement and Plan of Merger effectively changing the name of the Company to Fona Inc., a Nevada corporation (“Re-incorporation Merger”) and simultaneously adopting the capital structure of Fona Inc., which includes total authorized capital stock of 800,000,000 shares, of which 780,000,000 are common stock and 20,000,000 are blank check preferred stock. The preferred stock may be issued from time to time in one or more series with such designations, preferences and relative participating, optional or other special rights and qualifications, limitations or restrictions there of, as shall be stated in the resolutions adopted by the Corporation’s Board providing for the issuance of such preferred stock or series thereof.




1



 


On March 3, 2009, the shareholders also approved and ratified a January 22, 2008 Assignment Agreement under which the Company assigned the software and other rights relating to its Rent411 services, including the license with Desfaire, Inc. and substantially all of its worldwide copyrights, trademarks and other assets, consisting of fully depreciated office equipment and furniture with nominal market value, to The Boosalis Group, Inc., a company owned by Nick T. Boosalis, in consideration for which The Boosalis Group, Inc. assumed outstanding indebtedness of the Company totaling $34,714 and the issuance of a total of 1,980,834 shares of the Company’s common stock, including: 498,237 shares approved in December 2007 and 39,957 in December 2008 to Nick T. Boosalis for forgiveness of loans to the Company in the aggregate principal amount of $74,735 and $5,994, respectively; 322,047 shares approved in December 2007 to Richard Dillon, a former officer and director of the Company, for forgiveness of loans to the Company totaling $48,307; and 1,100,000 shares approved in December 2007 to Desfaire, Inc. for a cash payment of $11,000 and the payment on behalf of the Company of software development costs of more than $125,000.


On March 24, 2009, the Articles of Merger of Fonahome Corporation, a Minnesota Corporation, into Fona, Inc., a Nevada Corporation, were filed with the Nevada Secretary of State.


On April 1, 2009, the Board of Directors approved the issuance of 3,954,950 shares of our common stock (representing 50.1% of our outstanding shares of common stock following the issuance of such stock), including 1,977,475 shares issued to each of Sanford Schwartz and Michael Friess, each subsequently elected an officer and director of the Company, in consideration for the payment by each of $10,000, $5,000 paid in cash and $5,000 paid by the issuance to the Company of a promissory note. The notes were paid in May, 2009. On April 1, 2009, following the stock issuances to Mr. Schwartz and Mr. Friess, there were 7,894,111 outstanding shares of our common stock.


On April 22, 2009, the Board of Directors accepted the resignation of Nick T Boosalis and appointed Michael Friess as President, CEO, and Chairman of the Board, Sanford Schwartz as Vice President and a director, and Chloe DiVita as Secretary, Treasurer, CFO and a director of the Company.


On June 6, 2014, Evolutionary Genomics, Inc. (“Evolutionary Genomics”) entered into a Securities Purchase Agreement (the “First SPA”) whereby Michael Friess, the former Chairman of the Board, President and Chief Executive of the Company and Sanford Schwartz, member of the Company’s Board of Directors, agreed to sell, and Evolutionary Genomics, agreed to purchase, 366,000 shares of Common Stock from each of Messrs. Friess and Schwartz for an aggregate purchase price consideration of $145,000.  The First SPA further gave Evolutionary Genomics an option to purchase an additional 1,611,475 shares of Common Stock from each of Messrs. Friess and Schwartz for an aggregate purchase price consideration of $10,000 (the “Friess-Schwartz Option”).

 

In conjunction with the First SPA, Evolutionary Genomics entered into a Securities Purchase Option Agreement with Nick Boosalis, a shareholder of the Company, Desfaire, Inc., a Minnesota corporation and affiliate of Nick Boosalis, and The Boosalis Group, Inc., a Minnesota corporation and also an affiliate of Nick Boosalis, for the purchase of an option to acquire an aggregate of 2,252,233 shares of Common Stock (the “Boosalis Option”).  


On October 1, 2014, Evolutionary Genomics entered into a Securities Purchase Agreement (the “Second SPA”) with Michael Friess, Sanford Schwartz, Nick Boosalis, Desfaire, Inc. and The Boosalis Group, Inc., pursuant to which, in consideration of $110,000, Evolutionary Genomics purchased, in the aggregate, 5,201,423 shares (the “Shares”) of the Company’s Common Stock.  Mr. Warnecke, the Company’s Chief Financial Officer, Treasurer Secretary and a Director prior to the Second SPA, is the Chief Executive Officer of Evolutionary Genomics and holder of 782,539 shares of the Series B-2 Preferred Stock, representing 64.2% of the issued and outstanding shares of preferred stock of Evolutionary Genomics, and 1,032,780 shares of commons stock, or 26.8% of the issued and outstanding common stock of Evolutionary Genomics.  As a result of the Second SPA, there was a change in control of the Company.  Evolutionary Genomics currently owns 5,933,423 shares of the Company’s Common Stock, or 75.16%.


Other than the consummation of the Amended and Restated Agreement and Plan of Merger dated March 2, 2015 by and among Evolutionary Genomics, EG I, LLC, a Colorado limited liability company, the Company, Fona Merger Sub, Inc., a Delaware corporation and Fona Merger Sub, LLC, a Colorado limited liability company (the “Merger Agreement”), there are no plans or proposals which relate to, or could result in, a further change in control at this time.  The Company and the Board may, at any time and from time to time, review or reconsider their position, change their purpose or formulate plans or proposals with respect to a change in control.




2



 


Following the closing of the Second SPA, (i) Virginia Orndorff and Mark Boggess were appointed as directors of the Company, (ii) Messrs. Friess and Schwartz’s voluntarily resigned as officers and directors of the Company, (iii) Steve B. Warnecke, the Company’s Chief Financial Officer, was appointed the Company’s President, Chief Executive Officer and Chairman of the Board and (iv) Walter Messier was appointed the Company’s Secretary and Treasurer.  Further, on October 1, 2014 as a part of the Second SPA the Friess-Schwartz Option and the Boosalis Option were cancelled.


Since December 2007, the Company has had insignificant operations. As such, the Company may presently be defined as a "shell" company, whose sole purpose at this time is to locate and consummate a merger or acquisition with a private entity.


The Company has opted to register its common stock pursuant to section 12(g) of the Securities Exchange Act of 1934 in an effort to maximize shareholder value. The best use and primary attraction of the Company as a merger partner or acquisition vehicle will be its status as a reporting public company. Any business combination or transaction is expected to result in a significant issuance of shares and substantial dilution to present stockholders of the Company.


The proposed business activities described herein classify the Company as a "blank check" company. Many states have enacted statutes, rules and regulations limiting the sale of securities of "blank check" companies in their respective jurisdictions. Management does not intend to undertake any additional offerings of the Company's securities, either debt or equity, until such time as the Company has successfully implemented its business plan described herein.


The Company maintains headquarters at the office of its Chief Executive Officer. The Company does not maintain a Web site. The Company is not required to deliver an annual report to security holders and at this time does not anticipate the distribution of such a report. The Company will file reports with the SEC.


The public may read and copy any materials the Company files with the SEC in the SEC’s Public Reference Section, Room 1580, 100 F Street N.E., Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Section by calling the SEC at 1-800-SEC-0330. Additionally, the SEC maintains an Internet site that contains reports, proxy, and information statements, and other information regarding issuers that file electronically with the SEC, which can be found at http://www.sec.gov .


GENERAL BUSINESS PLAN


At this time, the Company' intends to execute on the transactions contemplated in the Amended and Restated Agreement and Plan of Merger dated March 2, 2015.  There can be no guarantee that those transactions will be completed.  If those transactions are not completed the Company will seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to it by persons or firms who seek or which desire to seek the perceived advantages of an Exchange Act registered corporation. Management anticipates that it may be able to participate in only one potential business venture because the Company has nominal assets and limited financial resources. See "FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA." This lack of diversification should be considered a substantial risk to shareholders of the Company because it will not permit the Company to offset potential losses from one venture against gains from another.


The Company will continue to incur legal and accounting costs, including the costs of preparing Form 8-K's, 10-K's and 10-Q's, agreements and related reports and documents. With limited resources, the Company relies on advances from its largest shareholder, Evolutionary Genomics, Inc. to fund those costs.  There can be no guarantee that Evolutionary Genomics, Inc. will continue to make such advances.




3



 


Evolutionary Genomics, LLC was formed on May 1, 2000 as a Colorado limited liability company for the purpose of developing and implementing a unique approach to identification of genes that control commercially valuable traits in crop plants and for use in human healthcare. On June 6, 2007, Evolutionary Genomics, LLC entered into a merger agreement with Evolutionary Genomics, Inc., a Delaware Corporation and Evolutionary Genomics Acquisition, Inc., a Delaware corporation and wholly-owned subsidiary of Evolutionary Genomics, Inc. resulting in Evolutionary Genomics, Inc. becoming the surviving entity. The merger became effective on July 31, 2007. Virginia Orndorff was Chief Executive Officer of Evolutionary Genomics through November 17, 2010 when Steve B. Warnecke was appointed by the Board of Directors as Chief Executive Officer. Ms. Orndorff remains as a member of the Board of Directors of Evolutionary Genomics.


EG I is a Colorado limited liability company formed on September 1, 2010. Combining both class A and class B interests, Evolutionary Genomics has 15.5% of the total 2,496,000 interests of EG I. The class A interests are entitled to receive 100% return of capital prior to any distribution to class B interests. EG I was formed to engage in research and commercialization of agricultural genetics and to engage in any related lawful business permitted by the Colorado Limited Liability Act. Evolutionary Genomics entered into a License and Service Agreement on October 14, 2010 with EG I under which Evolutionary Genomics will license certain patents, provide intellectual property and perform research services with the goal of identifying genes for the breeding, improvement and development of soybean plants.


COMPETITION


If the merger is not consummated, the Company will remain an insignificant participant among the firms which engage in the acquisition of business opportunities. There are many established venture capital and financial concerns which have significantly greater financial and personnel resources and technical expertise than the Company. In view of the Company's extremely limited financial resources and limited management availability, the Company will continue to be at a significant competitive disadvantage compared to the Company's competitors.


ITEM 1A. RISK FACTORS


A. Conflicts of Interest . There are certain conflicts of interest between us, our officers and directors and our majority shareholder, Evolutionary Genomics, Inc. As a result, conflicts of interest may arise that can be resolved only through their exercise of judgment in a manner which is consistent with their fiduciary duties to the Company.


B. Need for Additional Financing . We have very limited funds, and such funds are unlikely to be adequate to take advantage of any available business opportunities. Even if our funds prove to be sufficient to acquire an interest in, or complete a transaction with, a business opportunity, we may not have enough capital to exploit the opportunity. Our ultimate success may depend upon our ability to raise additional capital. We have not investigated the availability, source, or terms that might govern the acquisition of additional capital and will not do so until we determine a need for additional financing.


If additional capital is needed, there is no assurance that funds will be available from any source or, if available, that they can be obtained on terms acceptable to us. If such funds are not available, our operations will be limited to those that can be financed with our modest capital.


C. Regulation of Penny Stocks . Our securities will be subject to a Securities and Exchange Commission rule that imposes special sales practice requirements upon broker-dealers who sell such securities to persons other than established customers or accredited investors. For purposes of the rule, the phrase "accredited investors" means, in general terms, institutions with assets in excess of $5,000,000, or individuals having a net worth in excess of $1,000,000 or having an annual income that exceeds $200,000 (or that, when combined with a spouse's income, exceeds $300,000). For transactions covered by the rule, the broker-dealer must make a special suitability determination for the purchaser and receive the purchaser's written agreement to the transaction prior to the sale. Consequently, the rule may affect the ability of broker-dealers to sell our securities and also may affect the ability of our shareholders in this offering to sell their securities in any market that might develop.




4



 


Shareholders should be aware that, according to Securities and Exchange Commission Release No. 34-29093, the market for penny stocks has suffered from patterns of fraud and abuse. Such patterns include (i) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii) "boiler room" practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (iv) excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. The Company's management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities.


D. No Operating History or Revenue and Minimal Assets . The Company has had no operating history nor any revenues or earnings from operations since 1999. The Company has no significant assets or significant financial resources. The Company will, in all likelihood, sustain operating expenses without corresponding revenues, at least until the consummation of a business combination. This may result in the Company incurring a net operating loss which will increase continuously until the Company can consummate a business combination with a profitable business opportunity. There is no assurance that the Company can identify such a business opportunity and consummate such a business combination.


E. No Assurance of Success or Profitability . There is no assurance that we will consummate the transactions contemplated in the Amended and Restated Agreement and Plan of Merger dated March 2, 2015 or acquire any other business opportunity. Even if we should become involved in a business opportunity, there is no assurance that it will generate revenues or profits, or that the market price of our common stock will be increased thereby.


F. Dependence Upon Management; Limited Participation of Management . We will be heavily dependent upon the skills, talents, and abilities of our officers and directors to implement our business plan, and may, from time to time, find that the inability of such persons to devote their full-time attention to our business results in a delay in progress toward implementing our business plan. Furthermore, we will be entirely dependent upon the experience of our officers and directors in seeking, investigating, and acquiring a business and in making decisions regarding our operations. Because investors will not be able to evaluate the merits of our possible business acquisitions, they should critically assess the information concerning our officers and directors.


G. Indemnification of Officers and Directors . Our Articles of Incorporation provide that we will indemnify our directors, officers, employees, and agents to the fullest extent permitted by Nevada law. We will also bear the expenses of such litigation for any of our directors, officers, employees, or agents, upon such person's promise to repay us if it is ultimately determined that any such person shall not have been entitled to indemnification. This indemnification policy could result in substantial expenditures which we may be unable to recoup.


H. Dependence Upon Outside Advisors . To supplement the business experience of our officers and directors, we may be required to employ accountants, technical experts, appraisers, attorneys, or other consultants or advisors. The selection of any such advisors will be made by our officers without any input from shareholders. Furthermore, it is anticipated that such persons may be engaged on an "as needed" basis without a continuing fiduciary or other obligation to the Company. In the event management considers it necessary to hire outside advisors, they may elect to hire persons who are affiliates, if they are able to provide the required services.


I. Competition . If the transactions contemplated by the Amended and Restated Agreement and Plan of Merger dated March 2, 2015 are not consummated, the search for potentially profitable business opportunities is intensely competitive. We expect to be at a disadvantage when competing with many firms that have substantially greater financial and management resources and capabilities than we do. These competitive conditions will exist in any industry in which we may become interested.


J. No Foreseeable Dividends . We have not paid cash dividends on our common stock and do not anticipate paying such dividends in the foreseeable future.




5



 


K. Loss of Control by Present Management and Shareholders . We may consider an acquisition in which we would issue as consideration for the business opportunity to be acquired, an amount of our authorized but unissued common stock that would, upon issuance, represent the great majority of the voting power and equity of the Company. The result of such an acquisition would be that the acquired company's shareholders and management would control the Company, and our management could be replaced by persons unknown at this time. Such a merger would result in a greatly reduced percentage of ownership by our current shareholders.


L. Limited Public Market Exists . There is only a very limited public market for our common stock, and no assurance can be given that an active market will develop or that a shareholder ever will be able to liquidate his investment without considerable delay, if at all. If a market should develop, the price may be highly volatile. Factors such as those discussed in this "Risk Factors" section may have a significant impact upon the market price of our securities. Because of the low price of the securities, many brokerage firms may not be willing to effect transactions in the securities. Even if a purchaser finds a broker willing to effect a transaction in our securities, the combination of brokerage commissions, state transfer taxes, if any, and any other selling costs may exceed the selling price. Further, many lending institutions will not permit the use of such securities as collateral for any loans.


M. Concerns regarding the current economic situation . The United States and the global business community have experienced periods of instability that may effect our ability to successfully complete a business combination.


N. Risks Associated with the Merger. In addition to other information included in this report, you should consider all of the risks relating to the proposed merger and our operations following the business combination including but not limited to:


1)

If the Mergers are consummated, we may require substantial additional funding and may be unable to raise capital when needed, which could force us to delay, reduce or eliminate planned activities or result in our inability to continue as a going concern;

2)

We have relied on the availability of grant funding to fund some of our research efforts and our inability to compete successfully for these limited grant funding opportunities may significantly affect our results of operations and our ability to complete research projects;

3)

Efforts to protect our intellectual property rights and to defend claims against us can increase our costs and will not always succeed; any failures could adversely affect profitability or restrict our ability to do business;

4)

Genes that we have discovered and may discover in the future with expected desirable impact on traits may, upon further research and field trials, be revealed to also have undesirable impact on traits;

5)

Others may find additional genes or other methods of accomplishing the same desired outcome that our biotechnology does, rendering our biotechnology less valuable or commercializable;

6)

The successful development of our research efforts and commercialization of our biotechnology will be necessary for our growth and profitability;

7)

We rely heavily on our founder, Walter Messier, our current Chief Technology Officer. The loss of his services would have a material adverse effect upon us and our business and prospects;

8)

We are dependent on a technically trained workforce and an inability to retain or effectively recruit such employees could have a material adverse effect on our business, financial condition and results of operations;

9)

The cannabis industry, in which we hope to compete in the future, is relatively new, rapidly changing and subject to conflicting regulatory issues and it is very difficult to identify and describe all of the risks related to operating within this industry;

10)

Our investments in other entities may not be successful or may be illiquid for many years;

11)

We may pursue future growth through strategic acquisitions and alliances which may not yield anticipated benefits and may adversely affect our operating results, financial condition and existing business;

12)

Competition in agricultural biotechnology has significantly affected and will continue to affect our revenue and results of operations;

13)

Our customers are subject to extensive regulation affecting their use of our biotechnology, which may affect our revenue and profitability;

14)

The degree of public acceptance or perceived public acceptance of products made from our biotechnology can affect our sales and results of operations by affecting planting approvals, regulatory requirements and farmer purchase decisions;



6



 


15)

We are dependent upon other companies to integrate biotechnology that we have licensed to them into their breeding operations for our future license revenue; and

16)

The biotechnology industry is subject to rapid technological change, and if we fail to keep up with such change, our results of operations and financial condition could be adversely impacted.


ITEM 1B. UNRESOLVED STAFF COMMENTS


Not applicable.


ITEM 2. PROPERTIES


The Company has no properties and at this time has no agreements to acquire any properties. The Company currently maintains a mailing address at 1026 Anaconda Drive, Castle Rock, CO  80108, which is the address of the office of its Chief Executive Officer. The Company pays no rent for the use of this mailing address. The Company does not believe that it will need to maintain an office at any time in the foreseeable future in order to carry out its plan of operations described herein.


ITEM 3. LEGAL PROCEEDINGS


The Company is not a part to any pending legal proceedings, and no such proceedings are known to be contemplated.


ITEM 4. MINE SAFETY DISCLOSURES


Not applicable.



7



 



PART II


ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES


There is only a very limited market for the Company's securities.  As of March 2, 2014 the Company’s securities were included on the bulletin board under the symbol FNAM. There are no outstanding options or warrants to purchase shares of common stock or securities convertible into shares of the Company’s common stock. The Company has no obligations to register any of its shares of common stock under the Securities Act of 1933. As of March 2, 2015, 841,591 of the Company’s outstanding shares were eligible for transfer without registration under the Securities Act.


As of March 2, there were approximately 197 holders of the Company's Common Stock.


No dividends have been paid by the Company on any of its securities since the renewal of its charter and such dividends are not contemplated in the foreseeable future.


ITEM 6. SELECTED FINANCIAL DATA


 

 

Years Ended

 

 

 

December 31,

 

 

 

2014

 

 

2013

 

 

 

 

 

 

 

 

 

 

Revenues

  

$

  

  

$

  

Expenses

 

 

(27,139

)

 

 

(19,260

)

Net loss

 

 

(27,139

)

 

 

(19,260

)

Assets

 

 

 

 

 

991

 

Liabilities

 

 

13,672

 

 

 

78,162

 

Shareholder Deficit

 

 

(13,672

)

 

 

(77,171

)


ITEM 7. MANAGEMENTS DICUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS


Overview


The Company generated no revenues during the years ended December 31, 2014 and 2013, and management does not anticipate any revenues until following the conclusion of a merger or acquisition, if any, as contemplated by the Company’s business plan.


The Company has limited capital. The Company anticipates operational costs will be limited until the conclusion of a merger or acquisition, if any.


At December 31, 2014, the Company had no material commitments for capital expenditures.


General


At this time, the Company' intends to execute on the transactions contemplated in the Amended and Restated Agreement and Plan of Merger dated March 2, 2015.  There can be no guarantee that those transactions will be completed.  If those transactions are not completed the Company will seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to it by persons or firms who seek or which desire to seek the perceived advantages of an Exchange Act registered corporation. Management anticipates that it may be able to participate in only one potential business venture because the Company has nominal assets and limited financial resources. See "FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA." This lack of diversification should be considered a substantial risk to shareholders of the Company because it will not permit the Company to offset potential losses from one venture against gains from another.




8



 


The Company will continue to incur legal and accounting costs, including the costs of preparing Form 8-K's, 10-K's and 10-Q's, agreements and related reports and documents. With limited resources, the Company relies on advances from its largest shareholder, Evolutionary Genomics, Inc. to fund those costs.  There can be no guarantee that Evolutionary Genomics, Inc. will continue to make such advances.


Liquidity and Capital Resources.


The Company has no operating history as a "blank check" company and no material assets. At December 31, 2014 the Company had an accumulated deficit (including accumulated deficit during the development stage) of ($1,333,889) and a working capital deficit ($13,672). The report of the Company’s registered public accountants for the financial statements for the year ended December 31, 2014 included a going concern qualification.


ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK


Not required by smaller reporting companies.


ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA


See pages F-1 through F-12.


ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE


There are no disagreements with the accountants on accounting and financial disclosures.


ITEM 9A. CONTROLS AND PROCEDURES


(a) Evaluation of disclosure controls and procedures.


Under the supervision and with the participation of the Company’s management, including the principal executive officer and principal financial officer, as of the end of the period covered by this report, the Company conducted an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act. The Company’s disclosure controls and procedures are designed to provide reasonable assurance that the information required to be included in the Company’s reports to the Commission is recorded, processed, summarized and reported within the time periods specified in Commission rules and forms and to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that, as of the period covered by this report, the Company’s disclosure controls and procedures are not effective at these reasonable assurance levels for the reasons stated below.


Our internal control system is designed to provide reasonable cost-effective assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States. There is no assurance that our disclosure controls or our internal controls over financial reporting can prevent all errors. An internal control system, no matter how well designed and operated, has inherent limitations, including the possibility of human error. Because of the inherent limitations in a cost-effective control system, misstatements due to error may occur and not be detected. We monitor our disclosure controls and internal controls and make modifications as we believe appropriate given our financial resources and limited level of activities. Our intent in this regard is that our disclosure controls and our internal controls will improve as systems change and conditions warrant.




9



 


Management’s Annual Report on Internal Control over Financial Reporting.


Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States.


Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. Furthermore, smaller reporting companies such as the Company face additional limitations. Smaller reporting companies employ fewer individuals and find it difficult to properly segregate duties. Often, one or two individuals control every aspect of the Company’s operation and are in a position to override any system of internal control. Additionally, smaller reporting companies tend to utilize general accounting software packages that lack a rigorous set of software controls.


Our management, with the participation of the President, evaluated the effectiveness of the Company’s internal control over financial reporting as of December 31, 2014. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework. Based on this evaluation, our management, with the participation of the President, concluded that, as of December 31, 2014, our internal control over financial reporting was not effective due to the material weaknesses in the system of internal control described below.


Specifically, management identified the following control deficiencies. (1) The Company has not properly segregated duties as one or two individuals initiate, authorize, and complete all transactions. The Company has not implemented measures that would prevent the individuals from overriding the internal control system. The Company does not believe that this control deficiency has resulted in deficient financial reporting because the Chief Financial Officer is aware of his responsibilities under the SEC’s reporting requirements and personally certifies the financial reports. (2) The Company has installed accounting software that does not prevent erroneous or unauthorized changes to previous reporting periods and does not provide an adequate audit trail of entries made in the accounting software.


Accordingly, while the Company has identified certain material weaknesses in its system of internal control over financial reporting, it believes that it has taken reasonable cost-effective steps to ascertain that the financial information contained in this report is in accordance with generally accepted accounting principles. Management has determined that current resources would be appropriately applied elsewhere and when resources permit, they will alleviate material weaknesses through various steps.


(b) Changes in internal controls.


Our Certifying Officers have indicated that there were no changes in our internal controls over financial reporting or other factors that could significantly affect such controls subsequent to the date of his evaluation, and there were no such control actions with regard to significant deficiencies and material weaknesses.


ITEM 9B. OTHER INFORMATION


None.




10



 


PART III


ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.


Officers and Directors


The following table sets forth certain information concerning each of the Company's directors and executive officers:


Name

     

Age

     

Position

 

 

 

 

 

Steve B Warnecke

 

58

 

Chairman of the Board President, CEO

Walter Messier

 

59

 

Secretary and Treasurer

Mark Boggess

 

54

 

Director

Virginia Orndorff

 

64

 

Director


There are no agreements or understandings for any officer or director to resign at the request of another person and none of the above named officers and directors are acting on behalf of or will act at the direction of any other person.


There is no family relationship between any director or executive officer of the Company.


The Board of Directors presently has no committees.


Set forth below are the names of all directors and executive officers of the Company, all positions and offices with the Company held by each such person, the period during which he has served as such, and the business experience of such persons during at least the last five years:


Steve B. Warnecke was appointed Chief Financial Officer, Treasurer, Secretary and member of the board of directors of Fona on June 6, 2014, and became its principal executive officer as President, Chief Executive Officer and Chairman of the Board on October 1, 2014. Mr. Warnecke has served as a member of the board of directors of Evolutionary Genomics since September 2010 and was appointed as Chief Executive Officer in November 2010. Since November 2012, Mr. Warnecke has served part-time roles as Chairman of the Board of Directors and Chief Financial Officer for VetDC, Inc. and Senior Vice President of Children’s Hospital Colorado Foundation and Chairman of Children’s Partners Foundation (supporting Children’s Hospitals and cystic fibrosis research) since November 2011. He also is a member of the Board of Directors of CereScan and Bone Biologics, Inc. Previously, Mr. Warnecke served as Lead Independent Director and Audit Committee Chair for Evolving Systems, Inc. (NASDAQ: EVOL, an international telecom software company) from 2003 to 2011, as Chief Financial Officer of Targeted Medical Pharma, Inc. in 2011, as Chief Financial Officer and member of the Board of Directors for Bacterin International, Inc. (NASDAQ: BONE), a biologics and medical device company from 2008 to 2010, Chief Financial Officer for The Children’s Hospital Foundation from 2003 to 2008, member of the Board of Directors of Emmaus Life Sciences, Inc. in 2011, member of the Board of Directors of Boppy Company from 2005 to 2008, Senior Vice-President of Strategic Planning for First Data/Western Union (NYSE: FDC) from 2001 to 2002 and Chief Financial Officer for Frontier Airlines (former NASDAQ company acquired by Republic Airways) from 1999 to 2001. Mr. Warnecke graduated from the University of Iowa with a BBA in Accounting, Finance and Management and passed the Certified Public Accountant exam in 1979. The Fona board believes Mr. Warnecke is well qualified to serve on the Fona board due to his service on public company boards and financial and accounting background.




11



 


Virginia Orndorff was appointed as a director of the Company on October 1, 2014. She has served as a member of the Evolutionary Genomics board of directors since 2000. Ms. Orndorff was appointed Executive Director, Chief Executive Officer and Director of the Colorado Institute for Drug, Device and Diagnostic Development. Since 2012 Ms. Orndorff has served as Chief Executive Officer of SixOne Solutions, LLC, an early-stage oncology company. She also currently serves on Colorado’s State Board of Pharmacy since 2012. She served as Chief Executive Officer and President of Evolutionary Genomics from 2000 to 2010. From 1997 to 2000, Ms. Orndorff served as Vice President then President and Chief Executive Officer of GenoPlex, Inc. of Denver and served as Director of Technology/Business Development of NeXstar Pharmaceuticals, Inc. of Boulder, Colorado, from 1993 to 1997. From 1989 to 1993 she served as the Director of Biotechnology Programs for the Colorado Advanced Technology Institute in Denver. Ms. Orndorff was employed by the Georgia Institute of Technology as Manager of a biotechnology start-up incubator (the Health Science Technology Center) from 1987 to 1989; prior to that for eight years by Genex Corporation of Gaithersburg, Maryland, first as a Laboratory Supervisor then as Manager of Technology Assessment. From 1975 to 1979, Ms. Orndorff had served as a Microbiologist at Stanford Research Institute. She received a BA in Biology from the University of California at Santa Cruz, an MA in Microbiology from California State University at San Jose, and an MBA from Loyola College (where she graduated second in her class). The Fona board believes Ms. Orndorff is well qualified to serve on the Fona board due to her scientific background as well as her experience at both the operational and board levels in several companies.


Mark Boggess , Ph.D. was appointed as a director of the Company on October 1, 2014. He has served as a director of Evolutionary Genomics since 2009. Dr. Boggess has a diverse background in the animal sciences and animal industries. Born and raised on a typical Iowa farm, he served as a swine and beef cattle extension specialist with the University of Idaho in Twin Falls from 1990 to 1994 he was responsible for all swine extension and educational programming and served as the animal breeding resource specialist for the University beef extension team. From 1994 to 2004, Dr. Boggess served as President of Salmon Creek Farms, LLC where was responsible for development of the Salmon Creek Farms Natural Pork program and branded product line, at Independent Meat Company in Twin Falls, ID. From 2004 to 2009, Dr. Boggess assumed the position of Director of Animal Science for the National Pork Board where he was responsible for program direction and industry funding coordination for research in pork quality; nutritional efficiency; sow lifetime productivity; genomics-genetics; alternatives to antimicrobials; production-management systems and bio-technology. Dr. Boggess also served as the National Pork Board liaison for animal science to producers, academia, media, regulators and the National Pork Producers Council and directed numerous pork industry based advisory groups. From 2009 to 2014, Dr. Boggess served as the National Program Leader for Food Animal Production and the National Program Leader for Pasture, Forage and Rangeland Systems for the USDA Agriculture Research Service in Beltsville, Maryland. In this role, Dr. Boggess directed ARS research for diverse programs in genetics and genomics, nutrition, reproductive physiology, animal welfare and meat quality. Dr. Boggess also directed research to improve pasture and rangeland management practices and land-use strategies, improve and restore the ecology of western rangelands and improve the capacity and efficiency of forage based food animal production systems. Currently, Dr. Boggess serves as the Director of the U.S. Dairy Forage Research Center in Madison, WI. The USDFRC is unique in the world in that research programs are fully integrated and include research and expertise in soil science/ecology, forage breeding and management, forage handling and environmental engineering, animal nutrition, animal genetics/genomics, nutrient cycling/waste management, and dairy systems sustainability and management. In this role Dr. Boggess manages and directs the research programs for 21 scientists and approximately 75 support staff. The USDFRC includes two research farms in rural Wisconsin as well as offices and laboratories on the campus of the University of Wisconsin. Dr. Boggess attended Iowa State University receiving a BS degree in Animal Science in 1983. After receiving an MS degree from Cornell University with a major in Animal Breeding in 1985, Dr. Boggess returned to Iowa State University, receiving his PhD in 1990, also in Animal Breeding. The Fona board believes Dr. Boggess is well qualified to serve on the Fona board due to his extensive operational and management background in the animal sciences and animal industries.




12



 


Walter Messier , Ph.D. was appointed Secretary and Treasurer of the Company on October 1, 2014. He is a Founder of Evolutionary Genomics and has served as its Chief Technology Officer since 2000 and has served as its Secretary since 2007. Dr. Messier has published in such prestigious scientific journals as Nature, Nature Medicine, Current Biology, and Science. Dr. Messier is recognized as an authority on the use and interpretation of Ka/Ks algorithms. Dr. Messier’s research on the detection of molecular-level positive selection in the primates is well known. In addition to the research programs Dr. Messier developed and spearheads at Evolutionary Genomics, he is currently collaborating with colleagues in several areas, including identification and validation of novel targets for breast cancer therapeutics, identification and validation of novel targets for HIV/AIDS therapeutics, the role of molecular Darwinian selection in human speciation, and creation of more powerful algorithms for the detection of molecular Darwinian selection. Dr. Messier received his Masters of Science from the State University of New York at New Paltz, and his Ph.D. from the University of Albany (State University of New York).


ITEM 11. EXECUTIVE COMPENSATION


None of the Company's officers and/or directors receives any compensation for their respective services rendered to the Company, nor have they received such compensation since the renewal of the Company's charter. They have agreed to act without compensation until authorized by the Board of Directors, which is not expected to occur until the Company has generated revenues from operations after consummation of a merger or acquisition. As of the date of this registration statement, the Company has minimal funds available to pay directors. Further, none of the directors are accruing any compensation pursuant to any agreement with the Company.


It is possible that, after the Company successfully consummates a merger or acquisition with an unaffiliated entity, that entity may desire to employ or retain one or more members of the Company's management for the purposes of providing services to the surviving entity, or otherwise provide other compensation to such persons. However, the Company has adopted a policy whereby the offer of any post-transaction remuneration to members of management will not be a consideration in the Company's decision to undertake any proposed transaction. Each member of management has agreed to disclose to the Company's Board of Directors any discussions concerning possible compensation to be paid to them by any entity which proposes to undertake a transaction with the Company and further, to abstain from voting on such transaction.


It is possible that persons associated with management may refer a prospective merger or acquisition candidate to the Company. In the event the Company consummates a transaction with any entity referred by associates of management, it is possible that such an associate will be compensated for their referral. It is anticipated that this compensation would be either in the form of restricted common stock issued by the Company as part of the terms of the proposed transaction, or will be in the form of cash consideration. However, if such compensation is in the form of cash, such payment will be tendered by the acquisition or merger candidate, because the Company has minimal cash available. The amount of such compensation, if any, cannot be determined as of the date of this registration statement.


No retirement, pension, profit sharing, stock option or insurance programs or other similar programs have been adopted by the Registrant for the benefit of its employees.




13



 


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS


Principal Stockholders


The following table sets forth certain information as of March 2, 2015 regarding the beneficial ownership of the Company's common stock by (i) each stockholder known by the Company to be the beneficial owner of more than 5% of the Company's common stock, (ii) by each director and executive officer of the Company and (iii) by all executive officers and directors of the Company as a group. Each of the persons named in the table has sole voting and investment power with respect to common stock beneficially owned.


 

 

Number of

 

Percentage

 

 

Shares Owned

 

of Shares

Name and Address

 

or Controlled

 

Owned

 

 

 

 

 

Evolutionary Genomics, Inc. (1)

 

5,933,423

 

75.16%

1026 Anaconda Drive

 

 

 

 

Castle Rock, CO  80108

 

 

 

 

 

 

 

 

 

Steve B. Warnecke

 

5,933,423(1)

 

75.16%

1026 Anaconda Drive

 

 

 

 

Castle Rock, CO  80108

 

 

 

 

 

 

 

 

 

Virginia Orndorff

 

— (2)

 

 

1026 Anaconda Drive

 

 

 

 

Castle Rock, CO  80108

 

 

 

 

 

 

 

 

 

Mark Boggess

 

— (3)

 

 

1026 Anaconda Drive

Castle Rock, CO  80108

 

 

 

 

 

 

 

 

 

Walter Messier

 

— (4)

 

 

1026 Anaconda Drive

 

 

 

 

Castle Rock, CO  80108

 

 

 

 

 

 

 

 

 

Richard Dillon

 

576,571

 

7.30%

703 Oakland Ave

 

 

 

 

St. Paul, MN 55102

 

 

 

 

 

 

 

 

 

All Officers and Directors as a Group (1)

 

5,933,423

 

75.16%

———————

(1)

In addition to his role as Chief Executive Officer and Chairman of the Board of the Company, Mr. Warnecke is the Chief Executive Officer of Evolutionary Genomics and holder of 782,539 shares of the Series B-2 Preferred Stock, representing 64.2% of the issued and outstanding shares of preferred stock of Evolutionary Genomics, and 1,104,596 shares of commons stock, or 28.7% of the issued and outstanding common stock of Evolutionary Genomics. Mr. Warnecke disclaims beneficial ownership of the reported securities owned by Evolutionary Genomics except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission of beneficial ownership of such securities for any purpose.

(2)

Ms. Orndorff is a Director of the Company.

(3)

Dr. Boggess is a Director of the Company.

(4)

Dr. Messier is the Company’s Treasurer and Secretary.





14



 


ITEM 13. CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE


The Company’s officers and directors are also the officers and directors of Evolutionary Genomics, Inc. with whom the Company has entered into the Amended and Restated Agreement and Plan of Merger dated March 2, 2015. Mr. Warnecke is Evolutionary Genomics, Inc.’s Chief Executive Officer and Chairman of the Board and owns, directly or indirectly, 782,539 shares, or 64.2% of the Series B-2 Preferred Stock outstanding and 1,104,596 shares or 28.7% of the Common Stock outstanding as of December 31, 2014.  


Mr. Warnecke is also 100% owner of Sixty-Five Roses Ranch, Inc. which acts as the Managing Member of EG I, LLC, which is a party to the Amended and Restated Agreement and Plan of Merger dated March 2, 2015.  As of December 31, 2014, Mr. Warnecke’s ownership, either directly or indirectly of EG I, LLC  consisted of 495,772 of the 3,056,000 class A interests and Sixty-Five Roses Ranch, Inc. owned 169,778 of the 727,619 class B interests.


We maintain a mailing address at the offices of our chief executive officer, Steve B. Warnecke, located at 1026 Anaconda Drive, Castle Rock, CO  80108 for which we pay no rent. We anticipate that following the consummation of a business combination with an acquisition candidate, our office will be moved, but cannot predict future office or facility arrangements with our officers, directors or affiliates.


Although we have no current plans to do so, it is possible that we may enter into an agreement with an acquisition candidate requiring the sale of all or a portion of the common stock held by our largest shareholder to the acquisition candidate or principals thereof, or to other individuals or business entities, or requiring some other form of payment to our current shareholders, or requiring the future employment of specified officers and payment of salaries to them. Any payment to current shareholders in the context of an acquisition in which we are involved would be determined entirely by the largely unforeseeable terms of a future agreement with an unidentified business entity.


ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES


Audit Fees


The aggregate fees billed during the years ended December 31, 2014 and 2013 for professional services rendered by our principal accountant, Schumacher & Associates, Inc., for the audit of our annual financial statements and quarterly reviews were $10,500 and $7,600, respectively.


Audit Related Fees


The Company incurred no fees for the year ended December 31, 2013 and 2012 for audit related services by our principal accountant that were reasonably related to the performance of the audit or review of our financial statements, and not reported under Audit Fees above.


Tax Fees


There were no fees billed during the years ended December 31, 2014 and 2013 for professional services rendered by our principal accountant for tax preparation.


All Other Fees


We did not incur any fees for other professional services rendered by our principal accountant during the fiscal year ended December 31, 2014 and 2013.





15



 


PART IV


ITEM 15. EXHIBITS AND FINANCIAL STATEMENTS SCHEDULES


Exhibit Index


Exhibit No.

 

Description

10.1

 

Amended and Restated Agreement and Plan of Merger

31.1

 

Rule 13a-14(a)/15d-14(a) Certification

31.2

 

Rule 13a-14(a)/15d-14(a) Certification

32.1

 

Certification of Section 13(a) of the Securities Exchange Act of 1934

101.INS

 

XBRL Instance Document*

101.SCH

 

XBRL Taxonomy Extension Schema Document*

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document*

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document*

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document*

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document*

———————

*

In accordance with Regulation S-T, the XBRL-formatted interactive data files that comprise Exhibit 101 in this report shall be deemed furnished and not filed.







16



 



SIGNATURES


In accordance with Section 12 of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 

Fona, Inc.

 

 

 

 

 

 

 

 

 

March 4, 2015

By:

/s/ Steve Warnecke

 

 

 

Steve Warnecke

 

 

 

President, Chief Executive Officer,
Chief Financial Officer and a director

 

 

 

 

 

March 4, 2015

By:

/s/ Walter Messier

 

 

 

Walter Messier

 

 

 

Treasurer, Secretary

 

 

 

 

 

March 4, 2015

By:

/s/ Mark Boggess

 

 

 

Mark Boggess

 

 

 

Director

 


March 4, 2015

By:

/s/ Virginia Orndorff

 

 

 

Virginia Orndorff

 

 

 

Director

 








17



 


INDEX TO FINANCIAL STATEMENTS


FONA, INC.

FINANCIAL STATEMENTS

with

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



Report of Independent Registered Public Accounting Firm

F-2

 

 

Financial Statements:

 

 

 

Balance Sheets

F-3

 

 

Statements of Operations

F-4

 

 

Statement of Changes in Stockholders' (Deficit)

F-5

 

 

Statements of Cash Flows

F-6

 

 

Notes to Financial Statements

F-7











F-1



 


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Board of Directors

Fona, Inc.


We have audited the accompanying balance sheets of Fona, Inc. as of December 31, 2014 and 2013, and the related statements of operations, stockholders’ (deficit), and cash flows for the two years ended December 31, 2014 and 2013. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.


We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.


In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Fona, Inc. as of December 31, 2014 and 2013, and the results of its operations and its cash flows for the two years ended December 31, 2014 and 2013 in conformity with accounting principles generally accepted in the United States of America.


The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note 1, the Company has no business operations and has negative working capital and stockholders’ deficits, which raise substantial doubt about its ability to continue as a going concern. Management's plan in regard to this matter is also discussed in Note 1. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.


/s/ Schumacher & Associates, Inc.


Schumacher & Associates, Inc.

Certified Public Accountants

7931 S Broadway, #314

Littleton, CO   80122


March 2, 2015







F-2



 


FONA, INC.

BALANCE SHEETS


 

 

December 31,

 

 

 

2014

 

 

2013

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash

 

$

 

 

$

641

 

Prepaid Expenses

 

 

 

 

 

350

 

Total Current Assets

 

 

 

 

 

991

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$

 

 

$

991

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' (DEFICIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

 

$

1,650

 

Accounts payable, related parties

 

 

13,672

 

 

 

76,512

 

Total Current Liabilities

 

 

13,672

 

 

 

78,162

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

13,672

 

 

 

78,162

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Notes 1, 2, 3, 4 and 6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' (Deficit)

 

 

 

 

 

 

 

 

Preferred stock, $.001 par value 20,000,000 shares authorized, no shares issued and outstanding

 

 

 

 

 

 

Common stock, $.001 par value 780,000,000 shares authorized, 7,894,111 issued and outstanding

 

 

7,894

 

 

 

7,894

 

Additional paid-in capital

 

 

1,312,323

 

 

 

1,221,685

 

Accumulated (deficit)

 

 

(1,333,889

)

 

 

(1,306,750

)

 

 

 

 

 

 

 

 

 

TOTAL STOCKHOLDERS' (DEFICIT)

 

 

(13,672

)

 

 

(77,171

)

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT)

 

$

 

 

$

991

 


The accompanying notes are an integral part of the financial statements.




F-3



 


FONA, INC.

STATEMENTS OF OPERATIONS


 

 

Year Ended

 

 

 

December 31,

 

 

 

2014

 

 

2013

 

 

 

 

 

 

 

 

Revenues

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

 

 

Accounting and audit fees

 

 

12,210

 

 

 

7,600

 

Attorney fees

 

 

2,228

 

 

 

1,105

 

Filing fees

 

 

6,698

 

 

 

3,307

 

General corporate fees

 

 

750

 

 

 

750

 

Printing and mailing costs

 

 

 

 

 

 

Transfer agent fees

 

 

2,576

 

 

 

1,745

 

Other

 

 

41

 

 

 

48

 

Total Expenses

 

 

24,503

 

 

 

14,555

 

 

 

 

 

 

 

 

 

 

Net Operating (Loss)

 

 

(24,503

)

 

 

(14,555

)

 

 

 

 

 

 

 

 

 

Other Expenses:

 

 

 

 

 

 

 

 

Interest Expense

 

 

2,636

 

 

 

4,705

 

Total Other Expenses

 

 

2,636

 

 

 

4,705

 

 

 

 

 

 

 

 

 

 

Net Other (Expense)

 

 

(2,636

)

 

 

(4,705

)

 

 

 

 

 

 

 

 

 

Net (Loss)

 

 

(27,139

)

 

 

(19,260

)

 

 

 

 

 

 

 

 

 

Per Share

 

$

Nil

 

 

$

Nil

 

 

 

 

 

 

 

 

 

 

Weighted Average Shares Outstanding

 

 

7,894,111

 

 

 

7,894,111

 


The accompanying notes are an integral part of the financial statements.




F-4



 


FONA, INC.

STATEMENT OF CHANGES IN STOCKHOLDERS' (DEFICIT)

For the years ended December 31, 2014 and 2013


 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Preferred

 

 

Common Stock

 

 

Paid In

 

 

Accumulated

 

 

 

 

 

 

Stock

 

 

Shares

 

 

Amount

 

 

Capital

 

 

(Deficit)

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2012

 

 

 

 

 

7,894,111

 

 

 

7,894

 

 

 

1,216,980

 

 

 

(1,287,490

)

 

 

(62,616

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Imputed Interest

 

 

 

 

 

 

 

 

 

 

 

4,705

 

 

 

 

 

 

4,705

 

Net loss-year ended December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(19,260

)

 

 

(19,260

)

Balance at December 31, 2013

 

 

 

 

 

7,894,111

 

 

$

7,894

 

 

 

1,221,685

 

 

 

(1,306,750

)

 

 

(77,171

)

Imputed Interest

 

 

 

 

 

 

 

 

 

 

 

2,636

 

 

 

 

 

 

2,636

 

Forgiveness of Debt

 

 

 

 

 

 

 

 

 

 

 

88,002

 

 

 

 

 

 

88,002

 

Net loss-year ended December 31, 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(27,139

)

 

 

(27,139

)

Balance at December 31, 2014

 

$

 

 

 

7,894,111

 

 

$

7,894

 

 

$

1,312,323

 

 

$

(1,333,889

)

 

$

(13,672

)


The accompanying notes are an integral part of the financial statements.




F-5



FONA, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2014 and 2013



FONA, INC.

STATEMENTS OF CASH FLOWS


 

 

For the Year Ended

 

 

 

December 31,

 

 

 

2014

 

 

2013

 

 

 

 

 

 

 

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

Net (loss)

 

$

(27,139

)

 

$

(19,260

)

 

 

 

 

 

 

 

 

 

Adjustments to reconcile net loss to net cash (used in) operating activities:

 

 

 

 

 

 

 

 

Non cash interest

 

 

2,636

 

 

 

4,705

 

(Decrease) increase in accounts payable and accrued expenses

 

 

(1,650

)

 

 

1,200

 

Decrease in prepaid expenses

 

 

350

 

 

 

187

 

 

 

 

 

 

 

 

 

 

Net Cash (Used in) Operating Activities

 

 

(25,803

)

 

 

(13,168

)

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

 

 

Net Cash Provided by Investing Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

Sale of common stock

 

 

 

 

 

 

Advances (net) from related parties

 

 

25,162

 

 

 

13,695

 

 

 

 

 

 

 

 

 

 

Net Cash Provided by Financing Activities

 

 

25,162

 

 

 

13,695

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Decrease) Increase in Cash

 

 

(641

)

 

 

527

 

 

 

 

 

 

 

 

 

 

Cash, Beginning of Period

 

 

641

 

 

 

114

 

 

 

 

 

 

 

 

 

 

Cash, End of Period

 

$

 

 

$

641

 

 

 

 

 

 

 

 

 

 

Interest Paid

 

$

 

 

$

 

Income Taxes Paid

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Non-Cash Transactions:

 

 

 

 

 

 

 

 

Debt forgiveness

 

$

88,002

 

 

$

 


The accompanying notes are an integral part of the financial statements.




F-6



FONA, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2014 and 2013



(1) Summary of Accounting Policies, and Description of Business


This summary of significant accounting policies of Fona, Inc. (Company) is presented to assist in understanding the Company's financial statements. The financial statements and notes are representations of the Company's management who is responsible for their integrity and objectivity. These accounting policies conform to generally accepted accounting principles in the United States of America and have been consistently applied in the preparation of the financial statements.


(a) Organization and Description of Business


The Company was incorporated as Fonahome Corporation in 1990 under the laws of the State of Minnesota. On March 3, 2009, the Company held a shareholder meeting approving a migratory merger to Nevada and a name change to Fona, Inc., which became effective March 24, 2010.


The Company initially developed and marketed an interactive information and advertising service, but ceased all major operations in December, 1999. Currently the Company plans to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions.


Effective August 1, 2008, the Company commenced activities to become a reporting company with the Securities and Exchange Commission (“SEC”) with the intention to become a publicly trading company.


On March 2, 2015, Evolutionary Genomics, Inc. (“EG”), EG I, LLC (“EG I”) and the Company, Fona Merger Sub, Inc. (“Sub”) and Fona Merger Sub, LLC (“Sub LLC”), entered into an Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which, subject to certain conditions, Sub will merge with EG and Sub LLC will merge with EG I, with each EG and EG I surviving as wholly-owned subsidiaries of the Company (the “Mergers”).


(b) Use of Estimates in the Preparation of Financial Statements


The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.


(c) Per Share Information


Earnings (loss) per share of common stock is computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is not shown for periods in which the Company incurs a loss because it would be anti-dilutive.


(d) Basis of Presentation - Going Concern


The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern. However, the Company has no business operations and has negative working capital and stockholders’ deficits, which raise substantial doubt about its ability to continue as a going concern.








F-7



FONA, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2014 and 2013



(1) Summary of Accounting Policies, Continued


In view of these matters, continued operations of the Company is dependent upon the Company's ability to meet its financial requirements, raise additional capital, and the success of its future operations. The financial statements do not include any adjustments relating to the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company has financed its operations primarily through cash advances from related parties, which has advanced the Company a total of $11,674 for working capital on an “as needed” basis, including $25,162 during the year ended December 31, 2014. There is no assurance that these advances will continue in the future.


The Company has entered into an Agreement and Plan of Merger as amended by the Amended and Restated Agreement and Plan of Merger dated March 2, 2015 and believes that consummating this merger provides an opportunity for the Company to continue as a going concern.


(e) Recent Accounting Pronouncements


There were various accounting standards and interpretations issued during 2014 and 2013, none of which are expected to a have a material impact on the Company’s consolidated financial position, operations or cash flows.


The Financial Accounting Standards Board issued Accounting Standards Update No. 2014-15 in August 2014 regarding disclosure of uncertainties about an entity’s ability to continue as a going concern.  The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.


The Financial Accounting Standards Board issued Accounting Standards Update No. 2014-10 in June 2014 which eliminated certain financial reporting requirements for development stage companies.  This update was required to become effective for the Company as of the first annual period beginning after December 15, 2014 and early adoption is permitted.  The Company elected early adoption of this update.


(f) Risks and Uncertainties


The Company is subject to substantial business risks and uncertainties inherent in starting a new business. There is no assurance that the Company will be able to complete a business combination.


(g) Revenue Recognition


It is the Company's policy that revenue is recognized in accordance with SEC Staff Accounting Bulletin (SAB) No. 104, "Revenue Recognition." Under SAB 104, product revenues (or service revenues) are recognized when persuasive evidence of an arrangement exists, delivery has occurred (or service has been performed), the sales price is fixed and determinable and collectability is reasonably assured.


(h) Cash and Cash Equivalents


The Company considers cash and cash equivalents to consist of cash on hand and demand deposits in banks with an initial maturity of 90 days or less.


(i) Fair Value of Financial Instruments


Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ASC Subtopic 825-10 ("ASC 825-10"), "Disclosures About Fair Value of Financial Instruments." ASC 825-10 requires disclosure of fair value information about financial instruments when it is practicable to estimate that value. The carrying amount of the Company's cash, cash equivalents, accounts payable, accrued expenses, and accounts payable-related party approximate their estimated fair values due to their short-term maturities.



F-8



FONA, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2014 and 2013



(1) Summary of Accounting Policies, Continued


(j) Income Taxes


The Company records deferred taxes in accordance with Statement of Financial Accounting Standards (SFAS) ASC 740, “Accounting for Income Taxes”, which requires the use of assets and liability method of accounting for income taxes. The statement requires recognition of deferred tax assets and liabilities for temporary differences between the tax bases of assets and liabilities and the amounts at which they are carried in the financial statements, the effect of net operating losses, based upon the enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.


(k) Concentrations


Financial instruments that potentially subject the company to concentrations of credit risk consist principally of cash and cash equivalents. At December 31, 2014 and December 31, 2013, the Company had no amounts of cash or cash equivalents in financial institutions in excess of amounts insured by agencies of the U.S. Government.


(l) Reclassification


Certain amounts previously reported have been reclassified to conform to current presentation.


(m) Other


The Company has selected December 31 as its fiscal year end.


The Company has paid no dividends.


No advertising expense has been incurred.


The Company consists of one reportable business segment.


The Company has not entered into any leases.


(2) Income Taxes


Deferred income taxes arise from temporary timing differences in the recognition of income and expenses for financial reporting and tax purposes. The Company’s deferred tax assets consist entirely of the benefit from net operating loss (NOL) carry forwards, limited by the value of the shell. The net operating loss carry forward if not used, will expire in various years through 2032, and is severely restricted as per the Internal Revenue code if there is a change in ownership. The Company’s deferred tax assets are offset by a valuation allowance due to the uncertainty of the realization of the net operating loss carry forwards. Net operating loss carry forwards may be further limited by other provisions of the tax laws. Our income tax returns are no longer subject to Federal tax examinations by tax authorities for years before December 31, 2011.











F-9



FONA, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2014 and 2013



(2) Income Taxes, Continued


The Company’s deferred tax assets, valuation allowance, and change in valuation allowance are as follows:


Period Ending

 

Estimated
NOL Carry-
forward

 

NOL Expires

 

Estimated Tax
Benefit from
NOL

 

Valuation
Allowance

 

Change in
Valuation
Allowance

 

Net Tax
Benefit

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2013

 

605,810

 

Various

 

112,075

 

(112,075)

 

(3,563)

 

December 31, 2014

 

354,403

 

Various

 

65,565

 

(65,565)

 

46,510

 


Income taxes at the statutory rate are reconciled to the Company’s actual income taxes as follows:


Income tax benefit at statutory rate resulting from net operating loss carry forward

 

(15.0)%

State tax (benefit) net of Federal benefit

 

(3.5)%

Deferred income tax valuation allowance

 

18.5%

Actual tax rate

 


The change in valuation allowance for the year ended December 31, 2014 was primarily a result of the change in value of the Company resulting from the change of control under the Agreement and Plan of Merger dated June 6, 2014, partially offset by the net loss for the year ended December 31, 2014.


(3) Related Party Transactions


The Company’s officers and directors are also the officers and directors of Evolutionary Genomics, Inc. with whom the Company has entered into the Amended and Restated Agreement and Plan of Merger dated March 2, 2015. Mr. Warnecke is the Evolutionary Genomics, Inc.’s Chief Executive Officer and Chairman of the Board and owns, directly or indirectly, 782,539 shares, or 64.2% of the Series B-2 Preferred Stock outstanding and 1,104,596 shares or 28.7% of the Common Stock outstanding as of December 31, 2014.  


Mr. Warnecke is also 100% owner of Sixty-Five Roses Ranch, Inc. which acts as the Managing Member of EG I, LLC, which is a party to the Amended and Restated Agreement and Plan of Merger dated March 2, 2015.  As of December 31, 2014, Mr. Warnecke’s ownership, either directly or indirectly of EG I, LLC  consisted of 495,772 of the 3,056,000 class A interests and Sixty-Five Roses Ranch, Inc. owned 169,778 of the 727,619 class B interests.


The Company maintains a mailing address at the offices of its chief executive officer, Steve B. Warnecke, located at 1026 Anaconda Drive, Castle Rock, CO  80108 at no cost to the Company.


At December 31, 2013, the Company owed $76,512 to related parties for expenses of the Company. As of June 30, 2014, the Company owed $88,002 to related parties for the expenses of the Company.  On June 30, 2014, Sanford Schwartz and Michael Friess, the former majority shareholders of both the related party and the Company as of June 30, 2014, released the Company of debt totaling $88,002 resulting in a reclassification of the related party debt to additional paid in capital.  For the six months ended December 31, 2014, Evolutionary Genomics, Inc., the majority shareholder of the Company as of December 31, 2014, advanced $13,672 in payment of expenses on behalf of the Company. The advances are uncollateralized, bear no interest and are due on demand.


(4) Amended and Restated Agreement and Plan of Merger


On June 6, 2014, the Company, Evolutionary Genomics, Inc. (“EG”), EG I, LLC (“EG I”), Fona Merger Sub, Inc., (“Sub”) and Fona Merger Sub, LLC (“Sub LLC”) entered into an Agreement and Plan of Merger as amended by the Amended and Restated Agreement and Plan of Merger dated March 2, 2015 (the “Merger Agreement”), pursuant to which, subject to certain conditions, Sub will merge with EG and Sub LLC will merge with EG I, with each EG and EG I surviving as wholly-owned subsidiaries of the Company.



F-10



FONA, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2014 and 2013



(4) Amended and Restated Agreement and Plan of Merger, Continued


Pursuant to the terms of the Merger Agreement, at the effective time of the Mergers, the Company shall cause to be paid or issued to stockholders of record of EG as of the effective time of the Mergers, 308,821,675 newly issued shares of common stock, par value $0.001 per share of the Company giving them 86.2% of the combined company and 47,323,188 shares of Common Stock to the members of EG I giving them 13.3% of the combined company. The original shareholders of the Company shall retain 1,960,688 shares, or .5% (or one-half of one percent) of the combined company.  The closing of the Mergers shall occur on or before December 31, 2015 (“Closing”).  EG and EG I may at any time mutually agree to change the method of effecting the business combination, including entering into an appropriate amendment to the Merger Agreement.  The Mergers are intended to be a transaction or transactions described in Section 351 of the Internal Revenue Code (the “Code”).


The completion of the Mergers are subject to the satisfaction or waiver of certain closing conditions, including, without limitation, (i) the approval and adoption by the EG Stockholders and EG I Members of the Merger Agreement, (ii) the issuance of the Merger consideration in connection with the consummation of the Mergers, (iii) the effectiveness of a joint proxy statement/prospectus included in the Company’s registration statement on Form S-4, (iv) the effectiveness of a Registration Statement on Form S-1 to register certain shares held by certain shareholders of Company, (v) holders of either securities in EG and EG I shall not be entitled to dissenters’ or appraisal rights, (vi) absence of certain orders or regulations prohibiting the consummation of the Mergers, (vii) the effectiveness of a 1 for 60.8826565 shares reverse split of the Common Stock, and (vii) the approval or consent of any governmental authorities and third parties with respect to the transactions contemplated by the Merger Agreement.  


The Merger Agreement contains certain termination rights for EG, EG I and the Company. The Merger Agreement may be terminated for reasons, including but not limited to, the following:  (i) the mutual consent of the parties upon a majority vote of the boards of directors of the Company and EG or the board of managers of EG I, (ii) by any party to the Merger Agreement if any required governmental approval is denied, (iii) by any party to the Merger Agreement if the Merger is not consummated on or before December 31, 2015, (iv) by the board of managers of EG I or board of directors of EG if the Company, Sub or Sub LLC enter into any binding agreement that is not contemplated by the Merger Agreement, or (v) the occurrence of a material adverse effect that individually has or could reasonably be expected to have a material adverse effect on the Company, Sub or Sub LLC.

 

On June 6, 2014, the Company entered into a Securities Purchase Agreement (the “First SPA”) whereby Michael Friess, the Chairman of the Board, President and Chief Executive of the Company and Sanford Schwartz, member of the Company’s Board of Directors, agreed to sell, and EG, agreed to purchase, 366,000 shares of common stock from each of Messrs. Friess and Schwartz for an aggregate purchase price consideration of $145,000.  The First SPA further gave EG an option to purchase an additional 1,611,475 shares of common stock from each of Messrs. Friess and Schwartz for an aggregate purchase price consideration of $10,000 (the “Friess-Schwartz Option”).


In conjunction with the First SPA, EG entered into a securities purchase agreement with Nick Boosalis, a shareholder of Company, Desfaire, Inc., a Minnesota corporation and affiliate of Nick Boosalis, and The Boosalis Group, Inc., a Minnesota corporation and also an affiliate of Nick Boosalis, for the purchase of an option to acquire an aggregate of 2,252,233 shares of common stock of the Company (the “Boosalis Option”).  


On October 1, 2014, EG entered into a Securities Purchase Agreement (the “Second SPA”) with Michael Friess, Sanford Schwartz, Nick Boosalis, Desfaire, Inc. and The Boosalis Group, Inc., pursuant to which, in consideration of $110,000, EG purchased, in the aggregate, 5,201,423 shares of Company’s common stock.  As a result of the Second SPA, there was a change in control of Company.  EG currently owns 5,933,423 shares of Company’s common stock, or 75.16%.  The source of the funds for the purchase price for the shares of common stock was the working capital of EG. Simultaneously with the closing of the Second SPA, and in conjunction with the change in control, (i) Virginia Orndorff and Mark Boggess were appointed as directors of Company in addition to their roles as directors of EG and (ii) Messrs. Friess and Schwartz’s resigned as directors of Company.




F-11



FONA, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2014 and 2013



(5) Common Stock


Pursuant to the Articles of Incorporation of Fona, Inc., the Company is authorized to issue 780,000,000 common shares with $.001 par value. There were 7,894,111 shares of common stock issued and outstanding at December 31, 2014. There were no preferred shares outstanding as of December 31, 2014.


On March 3, 2009, the Board of Directors unanimously approved an Agreement and Plan of Merger effectively changing the name of the Company to Fona Inc., a Nevada corporation (“Re-incorporation Merger”) and simultaneously adopting the capital structure of Fona Inc., which includes total authorized capital stock of 800,000,000, of which 780,000,000 are common stock, with a par value of $.001 per share and 20,000,000 are blank check preferred stock, with a par value of $.001 per share.


(6) Subsequent Events


The Company has evaluated events subsequent to December 31, 2014 and through the date the financial statements were available to be issued, to assess the need for potential recognition or disclosure in this report. As discussed in Note 4, the Company entered into the Amended and Restated Agreement and Plan of Merger as of March 2, 2015.






F-12


 


EXHIBIT 10.1

AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER


THIS AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER (the “ Agreement ”) is made and entered into this 2nd day of March, 2015 (the “ Execution Date ”), by and among Fona, Inc., a Nevada Corporation (“ Parent ”), Fona Merger Sub, Inc., a Delaware Corporation (“ Sub ”), Fona Merger Sub, LLC, a Colorado limited liability company (“ Sub LLC ”, together with Sub and Parent, collectively the “ Parent Entities ”), Evolutionary Genomics, Inc., a Delaware Corporation (“ EG ”) and EG I, LLC,  a Colorado limited liability Company (“ EG I ”).


Premises


A.

This Agreement provides for Parent’s acquisition of EG and EG I through two simultaneous Mergers (as defined below) whereby (i) Sub shall merge with EG, and (ii) Sub LLC shall merge with EG I. Following these Mergers, EG and EG I shall be wholly owned subsidiaries of Parent. In connection with these simultaneous Mergers, Parent shall issue a total of 308,821,675 shares of common stock, par value $0.001 per share (the “ Parent Common Stock ”), to the holders of the EG Shares (as defined below)  (the “ EG Shareholders ”) and 47,323,188 to the holders of the EG Membership Interests (as defined below) (the “ EG I Members ”).


B.

Holders of a majority of the EG Shares, holders of a majority of the EG I Membership Interests (as defined below), the Board of Directors of Parent, the Board of Directors of EG, and the Board of Managers of EG I have determined, subject to the terms and conditions set forth in this Agreement, that the transactions contemplated hereby are desirable and in their respective best interests.  This Agreement is being entered into for the purpose of setting forth the terms and conditions of the proposed Mergers.


C.

Under the terms of this Agreement, (i) EG will merge with Sub with EG being the surviving entity (“ EG Merger ”), and (ii) EG I will merge with Sub LLC with EG I being the surviving entity (“ EG I Merger ”, and together with the EG Merger, the “ Mergers ”).


Agreement


NOW, THEREFORE, on the stated premises and for and in consideration of the mutual covenants and agreements hereinafter set forth and the mutual benefits to the parties to be derived here from, it is hereby agreed as follows:


ARTICLE I

THE MERGERS


Section 1.1

Closing. The closing of this Agreement (the “ Closing ”) shall occur upon the filing of the EG Certificate of Merger and EG I Certificate of Merger (as defined below) with each of the Secretary of State of Delaware and the Secretary of Colorado on or before  December 31, 2015 (the “ Closing Date ”). The Closing shall occur at the offices of Ellenoff Grossman and Schole LLP at 1345 Avenue of the Americas, New York, New York 10105. At the Closing, all of the documents, certificates, agreements, opinions and instruments referenced in this Agreement will be executed and delivered as described herein and all actions to be taken at the Closing shall be deemed to be taken simultaneously. Parent Entities, EG and EG I may at any time mutually agree to change the method of effecting the business combination, including by entering into an appropriate amendment to this Agreement (to the






 


extent such amendment only changes the method of effecting the business combination and does not substantively affect this Agreement or the rights and obligations of the parties or their respective stockholders hereunder); provided, however, that no such change shall (i) alter or change the amount or kind of the merger consideration provided for in this Agreement or (ii) materially impede or delay consummation of the transactions contemplated by this Agreement.

Section 1.2

EG Merger Effective Time.  Subject to the provisions of this Agreement, at the time of the Closing, EG shall cause the EG Merger to be consummated by filing with the Secretary of State of the State of Delaware a certificate of merger (the “ EG Certificate of Merger ”), in such form as required by, and executed and acknowledged by the parties in accordance with, the relevant provisions of the General Corporation Law of the State of Delaware (the “ DGCL ”) and shall make all other filings or recordings required under the DGCL in connection with the EG Merger. The EG Merger shall become effective upon the filing of the EG Certificate of Merger with the Secretary of State of the State of Delaware or at such later time as Parent and EG shall agree and shall specify in the EG Certificate of Merger (the time at which the EG Merger becomes effective being hereinafter referred to as the “ EG Effective Time ”).

Section 1.3

EG I Merger Effective Time.  Subject to the provisions of this Agreement, at the time of the Closing, EG I  shall cause the EG I Merger to be consummated by filing with the Secretary of State of the State of Colorado a certificate of merger (the “ EG I Certificate of Merger ”), in such form as required by, and executed and acknowledged by the parties in accordance with, the relevant provisions of the [Colorado Revised Statutes (“ CRS ”)] and shall make all other filings or recordings required under the CSR in connection with the EG I Merger. The EG I Merger shall become effective upon the filing of the EG I Certificate of Merger with the Secretary of State of the State of Colorado or at such later time as Parent and EG I shall agree and shall specify in the EG I Certificate of Merger (the time at which the EG I Merger becomes effective being hereinafter referred to as the “ EG I Effective Time ”).


Section 1.4

EG Surrender and Exchange of Certificates .  At or promptly after the Closing Date and upon surrender of a certificate or certificates representing the issued and outstanding shares of EG common stock, par value $0.001 per share (“ EG Common Stock ”), and issued and outstanding preferred shares, par value $0.001 per shares (“ EG Preferred Stock ”, together with EG Common Stock, “ EG Shares ”) (duly endorsed in blank or with executed power of attorney attached thereto in transferable form) that were outstanding immediately prior to the EG Merger, or an affidavit and indemnification in form reasonably acceptable to counsel for Parent stating that such stockholder has lost its certificate or certificates or that such have been destroyed, Parent shall issue to each record holder of EG surrendering such certificate, certificates or affidavit, a certificate or certificates registered in the name of such stockholder representing the number of shares of Parent Common Stock that such stockholder shall be entitled to receive as set forth in Exhibit A hereof. Until the certificate, certificates or affidavit is or are surrendered as contemplated by this Section 1.4, each certificate or affidavit that immediately prior to the Closing Date represented any outstanding shares of EG Shares shall be deemed at and after the Closing Date to represent only the right to receive upon surrender as aforesaid the Parent Common Stock specified in Exhibit A.  The capitalization of the combined companies following the transactions contemplated hereby will be as set forth in Exhibit A.


Section 1.5

EG I Surrender and Exchange of Certificates .  At or promptly after the Closing Date   the Class A membership interest and Class B membership interest of EG I (“ EG I Membership Interests ”) that were outstanding immediately prior to the EG I Merger shall be entitled to receive Parent Common Stock as set forth in Exhibit A hereof. The capitalization of the combined companies following the transactions contemplated hereby will be as set forth in Exhibit A.




2




 


Section 1.6

Parent Common Stock.  Parent agrees that it will cause the Parent Common Stock into which the EG Shares and EG I Membership Interests are exchanged on or subsequent to the Closing Date pursuant to Sections 1.4 and 1.5 to be available for such purposes.  

   

Section 1.7

Operation After Closing Date .  Each EG and EG I acknowledge that after the Closing Date, and compliance by Parent Entities with their respective duties and obligations hereunder, Parent shall have the absolute and unqualified right to deal with the assets and business of EG and EG I as its own property without limitation on the disposition or use of such assets or the conduct of such business.


Section 1.8

Mergers.


(a)

Immediately prior to the EG Merger, upon the terms and conditions set forth in this Agreement and in accordance with DGCL, at the EG Effective Time Sub shall merge with and into EG.  As a result of the EG Merger, the separate corporate existence of Sub shall cease and EG shall continue as the surviving entity of the EG Merger. EG shall survive and continue its corporate existence under the laws of the State of Delaware.


(b)

Immediately prior to the EG I Merger, upon the terms and conditions set forth in this Agreement and in accordance with CRS, at the EG I Effective Time Sub LLC shall merge with and into EG I.  As a result of the EG I Merger, the separate existence of Sub LLC shall cease and EG I shall continue as the surviving entity of the EG I Merger. EG I shall survive and continue its existence under the laws of the State of Colorado.    


(c)

Following the Mergers, Parent shall amend its Certificate of Incorporation to change its name to “EG Holdings, Inc.”


(d)

Effect on the EG Shares .  At the EG Effective Time, by virtue of the EG Merger and without any action on the part of Parent Entities, EG, or the holders of EG Shares:

(i)

Subject to Sections 1.8(f) and (g), the EG Shares (including any EG restricted stock) issued and outstanding immediately prior to the EG Effective Time, except for the EG Shares owned by Parent, Sub or EG, shall be converted into the right to receive 308,821,675 validly issued, fully paid and nonassessable shares of Parent Common Stock.   

(ii)

Notwithstanding anything in this Agreement to the contrary, immediately after the EG Effective Time, all EG Shares that are owned by EG, Parent or Sub shall be cancelled and shall cease to exist and no Parent Common Stock or other consideration shall be delivered in exchange therefor.


(e)

Effect on the EG I Membership Interests .  At the EG I Effective Time, by virtue of the EG I Merger and without any action on the part of Parent Entities, EG I or the holders of EG I Membership Interests:

(i)

Subject to Sections 1.8(f) and (g), EG I Membership Interests (including any EG I restricted securities) issued and outstanding immediately prior to the EG I Effective Time, except for membership interests owned by EG I, Parent or Sub LLC, shall be converted into the right to receive 47,323,188 validly issued, fully paid and nonassessable shares of Parent Common Stock.   



3




 


(ii)

Notwithstanding anything in this Agreement to the contrary, immediately after the EG I Effective Time, all of EG I Membership Interests that are owned by EG, Parent or Sub LLC shall be cancelled and shall cease to exist and no Parent Common Stock or other consideration shall be delivered in exchange therefor.  


(f)

 Fractional Shares.  No certificates or scrip representing fractional shares of Parent Common Stock to acquire fractional shares of Parent Common Stock or book-entry credit of the same shall be issued in exchange for the EG Shares and EG I Membership Interests.  Each holder of EG Shares and EG I Membership Interests who receives any portion of the Parent Common Stock who would otherwise have been entitled to receive a fraction of a share of Parent Common Stock to acquire a fraction of a share of Parent Common Stock shall have such fractional interest rounded up to the nearest whole number.


(g)

Issuance of Additional Parent Common Stock. The parties acknowledge and agree that to the extent EG issues additional shares subsequent to the date of this agreement prior to the Closing Date, the number of shares of Parent Common Stock to be issued to the EG Shareholders will be adjusted to reflect the additional shares issued by EG..  


(h)

No Liability.  None of the parties shall be liable to any holder of EG Shares and EG I Membership Interests for such Parent Common Stock (or dividends or distributions with respect thereto) or cash delivered to a public official pursuant to any applicable abandoned property, escheat or similar law.


Section 1.9

  Effects of the EG Merger.   The EG Merger shall have the effects set forth herein and in the applicable provisions of the DGCL. Without limiting the generality of the foregoing and subject thereto, at the EG Effective Time, all the property, rights, privileges, immunities, powers and franchises of  Sub shall vest in EG, and all debts, liabilities and duties of Sub shall become the debts, liabilities and duties of EG.


Section 1.10

  Effects of the EG I Merger.   The EG I Merger shall have the effects set forth herein and in the applicable provisions of the CRS. Without limiting the generality of the foregoing and subject thereto, at the EG I Effective Time, all the property, rights, privileges, immunities, powers and franchises of EG I and Sub LLC shall vest in EG I, and all debts, liabilities and duties of Sub LLC shall become the debts, liabilities and duties of EG I as the entity surviving the EG I Merger.


Section 1.11

Directors and Officers . In connection with the Mergers, Parent’s Board shall consist of three individuals after the Mergers, who shall initially consist of Steve B. Warnecke, Virginia Orndorff and Mark Boggess, each nominated by EG.  The Board of Directors of Parent shall appoint (i) Steve B. Warnecke as President, Chief Executive Officer and Chief Financial Officer, and (ii) Walter Messier as Secretary and Treasurer of Parent at Closing.


Section 1.12

Certain Adjustments to Capitalization .  If, between the date of this Agreement and the Closing Date, the outstanding Parent Common Stock is changed into a different number of shares or different class by reason of any reclassification, recapitalization, stock split, split-up, combination, or exchange of shares or a stock dividend or dividend payable in any other securities is declared effective with a record date within such period, or any similar event occurs, the Parent Common Stock and its allotment as set forth on Exhibit A  shall be appropriately adjusted to provide to each the EG Shareholders and EG I Members  the same economic effect as contemplated by this Agreement prior to such event.




4




 


Section 1.13

 Further Assurances.  From time to time, from and after the Closing Date, as and when reasonably requested by Parent, the EG Shareholders and EG I Members and the proper officers and directors of EG and EG I prior to the Closing Date shall, for and on behalf and in the name of the Parent or otherwise, execute and deliver all such deeds, bills of sale, assignments and other instruments and shall take or cause to be taken such further actions as Parent, Sub, Sub LLC or their respective successors or assigns reasonably may deem necessary or desirable in order to confirm or record or otherwise transfer to Parent, Sub or Sub LLC title to and possession of all of the properties, rights, privileges, powers, franchises and immunities of EG or EG I and otherwise to carry out fully the provisions and purposes of this Agreement.


Section 1.14

Tax-Free Exchange.  The Mergers are intended to be a transaction or transactions described in Section 351 of the Internal Revenue Code (the “ Code ”).  The parties hereto agree to report the Mergers as a transaction or transactions described in Section 351 of the Code.  None of the parties hereto will take or cause to be taken any action which would prevent the transactions contemplated by this Agreement from qualifying as a transaction or transactions described in Section 351 of the Code.  


ARTICLE II

REPRESENTATIONS, COVENANTS AND WARRANTIES OF

PARENT ENTITIES


As an inducement to and to obtain the reliance of EG and EG I and the EG Shareholders and EG I Members, Parent represents and warrants to EG, EG I and the EG Shareholders and EG I Members as follows:


Section 2.1

Organization.  


(a)

Parent is a corporation duly organized, and validly existing under the laws of Nevada and has the corporate power and is duly authorized, qualified, franchised and licensed under all applicable laws, regulations, ordinances and orders of public authorities to own all of its properties and assets and to carry on its business in all material respects as it is now being conducted, including qualification to do business as a foreign corporation in the jurisdiction in which the character and location of the assets owned by it or the nature of the business transacted by it requires qualification. The execution and delivery of this Agreement does not and the consummation of the transactions contemplated by this Agreement in accordance with the terms hereof will not violate any provision of Parent’s articles of incorporation or bylaws.  Parent has full power, authority and legal right and has taken all action required by law, its articles of incorporation, its bylaws or otherwise to authorize the execution and delivery of this Agreement.


Section 2.2

Capitalization.  The authorized capitalization of Parent consists of 780,000,000 shares, $0.001 par value per share (the “ Shares ”), and 20,000,000 shares of preferred stock (the “ Preferred Shares ”) at par value $0.001 per share.  Upon the issuance of an aggregate of 356,144,863 shares of Parent Common Stock to the EG Shareholders and EG I Members, as contemplated hereunder, there will be 358,105,551 outstanding shares of Parent Common Stock.  No Preferred Shares have been issued or are outstanding. There are no (i) outstanding options, warrants, puts, calls, convertible securities, preemptive or similar rights, (ii) bonds, debentures, notes or other indebtedness having general voting rights or that are convertible or exchangeable into securities having such rights, or (iii) subscriptions or other rights, agreements, arrangements, or commitments of any character, relating to the issued or unissued Parent Common Stock of, or other equity interests in, he Parent or obligating the Parent to issue, transfer, deliver or sell any options or Parent Common Stock of, or other equity interest in, the Parent or securities convertible into or exchangeable for such shares or equity interests, or obligating the Parent to



5




 


grant, extend or enter into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such equity interest.  There are no outstanding obligations of the Parent to repurchase, redeem or otherwise acquire any Parent Common Stock, capital stock of, or other equity interests in, the Parent or to provide funds to make any investment (in the form of a loan, capital contribution or otherwise) in any other entity. The securities described in this Agreement do not represent the contemplated split pursuant to Section 6.1(l) or any adjustments pursuant to Section 1.8(g)


Section 2.3

Approval of Agreement.  The directors of the Parent Entities have authorized the execution and delivery of the Agreement hereby and have approved the transactions contemplated hereby on behalf of the Parent Entities.

              

Section 2.4

No Conflict With Other Instruments.  The execution of this Agreement and the consummation of the transactions contemplated by this Agreement will not result in the breach of any term or provision of, or constitute an event of default under, any material indenture, mortgage, deed of trust or other material contract, agreement or instrument to which any of the Parent Entities are a party or to which any of their properties or operations are subject.


Section 2.5

Registration Rights.   There are not, as of the date hereof, and there will not be at the Closing Date any registration rights, and there is no voting trust, proxy, rights plan, anti-takeover plan or other agreement or understanding, to which the Parent Entities are a party or by which it is bound with respect to any equity security of any class of the Parent Entities, and there are no agreements to which the Parent is a party, or which the Parent has knowledge of, which conflicts with this Agreement or otherwise prohibits the consummation of the transactions contemplated hereby.


Section 2.6

Subsidiaries. Except as set forth on the Parent’s SEC Reports (hereinafter defined), the Parent does not have any predecessor corporation(s) or subsidiaries, and does not own, beneficially or of record, any shares of any other entity.


Section 2.7

Periodic Filings. The Parent has filed as of Closing all forms, reports, schedules, statements and other documents required to be filed or furnished to the Securities and Exchange Commission (“ SEC ”) under the requirements of the Securities Act of 1933, as amended (the “ Securities Act ”), or the Securities Exchange Act of 1934, as amended, (the “ Exchange Act ”), together with any amendments, restatements or supplements thereto. The reports, registration statements and definitive proxy statements filed by the Parent, including all Extensible Business Reporting Language filed with each such filing, with the SEC (the “ SEC Reports ”): (i) were prepared in all material respects in accordance with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and regulations thereunder and (ii) did not at the time they were filed with the SEC (except to the extent that information contained in any SEC Report has been revised or superseded by a later filed SEC Report) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.  All certifications and statements of the Parent required by (i) Rules 13a-14 or 15d-14 under the Exchange Act, or (ii) 18 U.S.C. §1350 (Section 906) of the Sarbanes-Oxley Act of 2002 (the “ Sarbanes-Oxley Act ”) with respect to any SEC Report are each true and correct.  


Section 2.8

Financial Statements . Each set of financial statements (including, in each case, any related notes thereto) contained in the SEC Reports as of Closing comply as to form in all material respects with the published rules and regulations of the SEC with respect thereto, were prepared in accordance with U.S. generally accepted accounting principles, applied on a consistent basis throughout the periods involved (except as may be indicated in the notes thereto or, in the case of unaudited statements, do not contain footnotes as permitted by Form 10-Q promulgated under the Exchange Act) and each in all material respects accurately reflects the Parent’s books and records as of the times and for



6




 


the periods referenced to therein and fairly presents in all material respects the financial position of the Parent at the respective dates thereof and the results of its operations and cash flows for the periods indicated, except that the unaudited interim financial statements were or are subject to normal adjustments which were not or are not expected to have a material adverse effect.


Section 2.9

Liabilities . There are no liabilities of the Parent Entities or any of its subsidiaries of any kind whatsoever, whether accrued, contingent, absolute, determined, determinable or other­wise, other than liabilities adequately reflected or reserved in the Parent’s financial statements contained in the SEC Reports.


Section 2.10

Tax Filings . The Parent Entities have filed all state, federal or local income and/or franchise tax returns required to be filed by it for the period of five (5) years preceding the date hereof.  Each of such income tax returns reflects the taxes due for the period covered thereby, except for amounts which, in the aggregate, are immaterial. The Parent Entities have no liabilities with respect to the payment of any federal, state, county, local or other taxes (including any deficiencies, interest or penalties), except for taxes accrued but not yet due and payable.


Section 2.11

Books and Records. All of the books and records of the Parent are complete and accurate in all material respects and have been maintained in the ordinary course and in accordance with applicable laws and standard industry practices with regard to the maintenance of such books and records.  The records, systems, controls, data and information of the Parent and its subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and direct control of the Parent or its accountants (including all means of access thereto and therefrom).


Section 2.12    Bankruptcy. None of the Parent or any of its subsidiaries has: (i) commenced a voluntary case, or had entered against it a petition, for relief under the federal bankruptcy code or any similar petition, order or decree under any federal or state law or statute relative to bankruptcy, insolvency or other relief for debtors; (ii) caused, suffered or consented to the appointment of a receiver, trustee, administrator, conservator, liquidator or similar official in any federal, state or foreign judicial or non judicial proceedings, to hold, administer or liquidate all or substantially all of its property; or (iii) made an assignment for the benefit of creditors.


Section 2.13

Broker Fees. No broker, investment banker or other person is entitled to any broker’s, finder’s or other similar fee or commission in connection with the transactions contemplated by this Agreement


Section 2.14

Foreign Corrupt Practices. None of the Parent or any of its subsidiaries, nor any director, officer, agent, employee or other person acting on behalf of the Parent or any of its subsidiaries has, in the course of its actions for, or on behalf of, the Parent (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee.


Section 2.15

Investment Company .  The Parent is not, and is not an affiliate of, and immediately following the Closing will not have become, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.




7




 


Section 2.16

Information . All disclosure provided to EG, EG 1, EG Shareholders and EG Members regarding the Parent, its business and the transaction contemplated hereby, furnished by or on behalf of   it executive officers are true and correct and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.


Section 2.17

Since the date of the most recent balance sheet included in the SEC Reports:


(i)

the Parent has been operated in the ordinary course of business as was operated in the past with no extraordinary actions or transactions.   


(ii)

there has not been: (A) any material adverse change in the business, operations, properties, assets or condition of the Parent or (B) any damage, destruction or loss to the Parent (whether or not covered by insurance) materially and adversely affecting the business, operations, properties, assets or condition of the Parent;


(iii)

the Parent has not: (A) amended its certificate of incorporation or bylaws except as required by this Agreement; (B) declared or made, or agreed to declare or make any payment of dividends or distributions of any assets of any kind whatsoever to stockholders or purchased or redeemed, or agreed to purchase or redeem, any of its capital stock; (C) waived any rights of value which in the aggregate are outside of the ordinary course of business or material considering the business of the Parent; (D) made any material change in its method of management, operation, or accounting; (E) entered into any transactions or agreements of any kind or nature outside the ordinary course of business; (F) made any accrual or arrangement for or payment of bonuses or special compensation of any kind or any severance or  termination pay to any present or former officer or employee; (G) borrowed any money ; or (H) made any material change to a material contract by which the Parent or any of  its assets is bound;


(iv)

the Parent has not: (A) granted or agreed to grant any options, warrants, or other rights for its stock, bonds, or other corporate securities calling for the issuance thereof; (B) borrowed or agreed to borrow any funds or incurred, or become subject to, any material obligation or liability (absolute or contingent); (C) paid or agreed to pay any material obligations or liabilities (absolute or contingent) other than current liabilities reflected in or shown on the most recent balance sheet and current liabilities incurred since that date in the ordinary course of business and professional and other fees and expenses in connection with the preparation of this Agreement and the consummation of the transactions contemplated hereby; (D) sold or transferred, or agreed to sell or transfer any of its assets, properties or rights or canceled, or agreed to cancel, any debts or claims; or (E) issued, delivered or agreed to issue or deliver, any stock, bonds or other corporate securities including debentures (whether authorized and unissued or held as treasury stock), except in connection with this Agreement; and


(v)

The Parent did not become subject to any law or regulation which materially and adversely affects, or in the future, may adversely affect, the business, operations, properties, assets or condition of the Parent as described in its financial statements.


Section 2.18

Litigation . Except as disclosed in Schedule 2.18 hereto, there is no legal action, suit, arbitration or other legal, administrative or other governmental proceeding pending or threatened against or affecting Parent or their respective properties, assets or business, and after reasonable investigation, neither Parent Entities nor their respective shareholders or members, as applicable, are aware of any incident, transaction, occurrence or circumstance that might reasonably be expected to result in or form the basis for any such action, suit, arbitration or other proceeding. Parent Entities are not in default with respect to any order, writ, judgment, injunction, decree, determination or award of any court or any governmental agency or instrumentality or arbitration authority.



8




 


Section 2.19

Contractual Obligations.   As of the date hereof, the Parent is not a party to and has no obligation to perform (absolute or contingent) under any oral or written: (i) profit sharing, bonus, deferred compensation, stock option, severance pay, pension benefit or retirement plan, (ii) agreement, contract, commitment or indenture relating to the borrowing of money, (iii) guaranty of any obligation; (iv) collective bargaining agreement; or (v) agreement with any present or former officer or director of the Parent. With respect to each contract to which Parent is a party: (i) the contract is legal, valid, binding and enforceable and in full force and effect, as applicable, and is legal, valid, binding, enforceable and in full force and effect with respect to each other party thereto, in either case subject to the effect of bankruptcy, insolvency, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and except as the availability of equitable remedies may be limited by general principles of equity; (ii) the contract will continue to be legal, valid, binding and enforceable and in full force and effect immediately following the Closing Date in accordance with its terms as in effect prior to the Closing Date, subject to the effect of bankruptcy, insolvency, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and except as the availability of equitable remedies may be limited by general principles of equity; and (iii) neither Parent nor any other party is in breach or default, and no event has occurred that with notice or lapse of time would constitute a breach or default by Parent, as applicable, or by any such other party, or permit termination, modification or acceleration, under such contract and (iv) no party has repudiated any provision thereof.  Parent is not a party to any oral contract.


Section 2.20

Regulatory Compliance. The Parent is in compliance with all laws applicable to it and the conduct of its business as currently conducted.  The Parent is not in conflict with, or in default or violation of, nor has it received any notice of any conflict with, or default or violation of: (i) any applicable law by which the Parent or any of its property or assets is bound or affected, or (ii) any agreement to which the Parent was a party or by which the Parent or any property, asset or right of the Parent was bound or affected, except where such violation, breach or default would not reasonably be expected to have a material adverse effect upon the business, prospects, management, properties, operations, condition (financial or otherwise) (“ Material Adverse Effect ”).    


Section 2.21

Book Entry . The Parent Common Stock is eligible for depository services provided by The Depository Trust Company.  


Section 2.22

Employees. Except as disclosed in the SEC Reports, the Parent has no officers, or directors. The Parent Entities have no employees, agents or consultants.  


Section 2.23

Condition of Properties .  All facilities, machinery, equipment, fixtures and other properties owned, leased or used by Parent are in reasonably good operating condition and repair, subject to ordinary wear and tear, and are adequate and sufficient for their respective businesses.


Section 2.24

Environmental Matters .  Parent is in compliance with all environmental Laws relating to their respective properties or facilities (including real property, especially business premises, buildings, land property, heritable building rights, etc.) used, leased or occupied by them.


Section 2.25

Title to Property and Encumbrances .  Parent has good, valid and indefeasible marketable title to all properties and assets used in the conduct of its business (except for property held under valid and subsisting leases that are in full force and effect and which are not in default) free of all Liens and other encumbrances, except Permitted Liens (as defined below) and such ordinary and customary imperfections of title, restrictions and encumbrances as do not, individually or in the aggregate, materially detract from the value of the property or assets or materially impair the use made thereof by Parent in its business. For purposes of this Agreement, “ Permitted Liens ” shall mean (a) Liens for taxes and assessments or governmental charges or levies not at the time due or in respect of which the validity thereof shall currently be contested in good faith by appropriate proceedings; (b) Liens in respect



9




 


of pledges or deposits under workmen’s compensation laws or similar legislation, carriers’, warehousemen’s, mechanics’, laborers’ and materialmens’ and similar Liens, if the obligations secured by such Liens are not then delinquent or are being contested in good faith by appropriate proceedings and (c) Liens incidental to the conduct of the business of the Parent that were not incurred in connection with the borrowing of money or the obtaining of advances or credits and that do not in the aggregate materially detract from the value of its property or materially impair the use made thereof by a company in its business.


Section 2.26

Indebtedness.   Schedule 2.26 hereto contains a true and complete list of Parent’s Indebtedness for Borrowed Money and all liabilities. For purposes of this Agreement, “ Indebtedness for Borrowed Money ” shall mean (a) all Indebtedness in respect of money borrowed including, without limitation, Indebtedness that represents the unpaid amount of the purchase price of any property and is incurred in lieu of borrowing money or using available funds to pay such amounts and not constituting an account payable or expense accrual incurred or assumed in the ordinary course of business of a company, (b) all Indebtedness evidenced by a promissory note, bond or similar written obligation to pay money or (c) all such Indebtedness guaranteed by a company or for which a company is otherwise contingently liable. Furthermore, for purposes of this Agreement, “ Indebtedness ” shall mean any obligation of a company which, under United States GAAP, is required to be shown on the balance sheet of a company as a liability. Any obligation secured by a mortgage, pledge, security interest, encumbrance, lien or charge of any kind (a “ Lien ”) shall be deemed to be Indebtedness, even though such obligation is not assumed by a company.

ARTICLE III

REPRESENTATIONS, COVENANTS AND WARRANTIES

OF EG AND EG I AND THE EG SHAREHOLDERS AND EG I MEMBERS


As an inducement to, and to obtain the reliance of the Parent Entities, (i) EG and the EG Shareholders, jointly and severally with regard to the representations and warranties of EG and the EG Shareholders, and (ii) EG I and the EG I Members, jointly and severally with regard to the representations and warranties of EG I and the EG I Members, severally represent and warrant to the Parent Entities to the best of their knowledge as follows:


Section 3.1

Organization and Operations.  


(a)  EG is a corporation duly organized, validly existing and in good standing under the laws of Delaware and has the corporate power and is duly authorized, qualified, franchised and licensed under all applicable laws, regulations, ordinances and orders of public authorities to own all of its properties and assets and to carry on its business in all material respects as it is now being conducted, including qualification to do business as a foreign entity in the country or states in which the character and location of the assets owned by it or the nature of the business transacted by it requires qualification.  The execution and delivery of this Agreement does not and the consummation of the transactions contemplated by this Agreement in accordance with the terms hereof will not, violate any provision of EG’s charter, governing documents or bylaws.  EG has full power, authority and legal right and has taken all action required by law, its articles of incorporation, bylaws or otherwise to authorize the execution and delivery of this Agreement.


(b)  EG I is a limited liability company duly formed, validly existing and in good standing under the laws of Colorado and is duly authorized, qualified, franchised and licensed under all applicable laws, regulations, ordinances and orders of public authorities to own all of its properties and assets and to carry on its business in all material respects as it is now being conducted, including qualification to do business as a foreign entity in the country or states in which the character and location of the assets owned by it or the nature of the business transacted by it requires qualification.  The execution and delivery of this



10




 


Agreement does not and the consummation of the transactions contemplated by this Agreement in accordance with the terms hereof will not, violate any provision of EG I’s certificate of formation or operating agreement, as amended.  EG I has full power, authority and legal right and has taken all action required by law, its certificate of formation or operating agreement or otherwise to authorize the execution and delivery of this Agreement.


Section 3.2

No Conflict With Other Instruments; Compliance with Laws.  


(a)

The execution of this Agreement and the consummation of the transactions contemplated by this Agreement will not result in the breach of any term or provision of, or constitute an event of default under, any material indenture, mortgage, deed of trust or other material contract, agreement or instrument to which EG or EG I is a party or to which any of its properties or operations are subject.


(b)

The business, products and operations of EG and EG I each have been and are being conducted in compliance in all material respects with all applicable laws, rules and regulations, except for such violations thereof for which the penalties, in the aggregate, would not have a Material Adverse Effect (as defined below) on their respective condition.


Section 3.3

Intentionally Omitted.


Section 3.4

Subsidiaries.

EG does not have any subsidiaries.  


Section 3.5

Capital Structure


(a)

The only authorized, issued and outstanding capital stock or other equity interests of EG as well as any other securities (including debt securities) of EG are (i) 1,219,244 shares of EG Preferred Stock, (ii) 3,853,164 shares of EG Common Stock, (iii) options to purchase 220,000 shares of EG Common Stock and (iv) warrants to purchase 135,937 shares of EG Common Stock.  All outstanding shares of capital stock of EG have been duly authorized and validly issued and are fully paid and non-assessable and were not issued in violation of any preemptive rights or other preferential rights of subscription or purchase other than those that have been waived or otherwise cured or satisfied and all such shares are free and clear of all liens, charges, encumbrances, claims and options of any nature.  None of the outstanding securities of EG has been issued in violation of any applicable foreign, federal or state securities Laws.


(b)

The only authorized, issued and outstanding membership interests or other equity interests of EG I as well as any other securities (including debt securities) of EG I are (i) 3,056,000 Class A membership interests, and (ii) 727,619 Class B membership interests.  All outstanding shares of EG Membership Interests have been duly authorized and validly issued and are fully paid and non-assessable and were not issued in violation of any preemptive rights or other preferential rights of subscription or purchase other than those that have been waived or otherwise cured or satisfied and all such shares are free and clear of all liens, charges, encumbrances, claims and options of any nature.  None of the outstanding securities of EG I has been issued in violation of any applicable foreign, federal or state securities Laws.


(c)

Except as disclosed in Section 3.6(a), there are no options, warrants, convertible securities, rights, commitments (including pre-emptive rights) or agreements pursuant to which either EG or EG I are bound to issue, deliver, sell, purchase, redeem or acquire or cause to be issued, delivered, sold, purchased, redeemed or acquired, shares of EG or membership interests of EG I or any other securities of EG and EG I.

 



11




 


(d)

There are not, as of the date hereof, and there will not be as of the date of this Agreement, any stockholder agreements, voting trusts or other agreements or understandings to which EG and EG I is a party or by which it is bound relating to the voting of any EG Shares and EG I Membership Interests.


Section 3.6

Authority; No Violations; Consents and Approvals.


(a)

EG has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby.  The execution and delivery of this Agreement and each of the agreements required to be executed in connection herewith and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of EG.  This Agreement and each of the agreements required to be executed in connection herewith have been duly executed and delivered by EG and constitutes a valid and binding obligation of EG enforceable in accordance with its terms, subject, as to enforceability, to bankruptcy, insolvency, merger and other laws of general applicability relating to or effecting creditors’ rights and to general principles of equity and limitations imposed on indemnity obligations by applicable federal and state securities laws.


(b)

EG I has all requisite authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby.  The execution and delivery of this Agreement and each of the agreements required to be executed in connection herewith and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of EG I.  This Agreement and each of the agreements required to be executed in connection herewith have been duly executed and delivered by EG I and constitutes a valid and binding obligation of EG I enforceable in accordance with its terms, subject, as to enforceability, to bankruptcy, insolvency, merger and other laws of general applicability relating to or effecting creditors’ rights and to general principles of equity and limitations imposed on indemnity obligations by applicable federal and state securities laws.


(c)

No consent, approval, order or authorization of, or registration, declaration or filing with, or permit from, any U.S. or non-U.S. court, administrative agency or commission or other governmental authority or instrumentality (a “ Governmental Entity ”), is required by, or with respect to, EG and EG I in connection with the execution and delivery of this Agreement by EG and EG I or the consummation by EG and EG I of the transactions contemplated hereby, as to which the failure to obtain or make would have a Material Adverse Effect on EG and EG I, except for: (A) the filing of a Certificate of Merger; (B) such filings and approvals as may be required by any applicable state securities, “blue sky” or takeover laws or (C) such filings as may be required in any jurisdiction where EG and EG I is qualified or authorized to do business as a foreign entity in order to maintains such qualification or authorization.


Section 3.7

Broker Fees .  No broker, investment banker or other person is entitled to any broker’s, finder’s or other similar fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of EG or EG I.


Section 3.8

Books and Records .  All of the books and records of EG and EG I are complete and accurate in all material respects and have been maintained in the ordinary course and in accordance with applicable laws, rules or regulations and standard industry practices with regard to the maintenance of such books and records.  The records, systems, controls, data and information of EG and EG I are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and direct control of EG and EG I or its accountants (including all means of access thereto and therefrom).




12




 


Section 3.9

Bankruptcy .   EG and EG I have not: (i) commenced a voluntary case, or had entered against it a petition, for relief under the federal bankruptcy code or any similar petition, order or decree under any federal or state law or statute relative to bankruptcy, insolvency or other relief for debtors; (ii) caused, suffered or consented to the appointment of a receiver, trustee, administrator, conservator, liquidator or similar official in any federal, state or foreign judicial or non judicial proceedings, to hold, administer or liquidate all or substantially all of its property; or (iii) made an assignment for the benefit of creditors.


Section 3.10

Personnel .  EG and EG I have reasonably complied in all material respects with all laws relating to the employment of labor, and neither EG nor EG I has encountered any material labor union difficulties. Other than pursuant to ordinary arrangements of compensation to personnel, neither EG nor EG I is under any obligation or liability to any of their respective officers, directors, consultants or staff members.


Section 3.11

Title to Property and Encumbrances .  Each EG and EG I has good, valid and indefeasible marketable title to all properties and assets used in the conduct of its business (except for property held under valid and subsisting leases that are in full force and effect and which are not in default) free of all Liens and other encumbrances, except Permitted Liens (as defined below) and such ordinary and customary imperfections of title, restrictions and encumbrances as do not, individually or in the aggregate, materially detract from the value of the property or assets or materially impair the use made thereof by EG and EG I in its respective business.  


Section 3.12

Condition of Properties .  All facilities, machinery, equipment, fixtures and other properties owned, leased or used by EG and EG I are in reasonably good operating condition and repair, subject to ordinary wear and tear, and are adequate and sufficient for their respective businesses.


Section 3.13

Tax Returns .  EG has timely filed all federal, state and foreign income and franchise tax returns required to be filed by them on or prior to the date hereof, and has paid all taxes shown thereon as due, and there is no tax deficiency that has been or might be asserted against them that might reasonably be expected to have a Material Adverse Effect.  All tax liabilities are adequately provided for on the books of EG and EG I, as applicable.

  Section 3.14

Litigation .  Except as disclosed in Schedule 3.14 hereto, there is no legal action, suit, arbitration or other legal, administrative or other governmental proceeding pending or threatened against or affecting EG, EG I or their respective properties, assets or business, and after reasonable investigation, neither EG, EG I nor their respective shareholders are aware of any incident, transaction, occurrence or circumstance that might reasonably be expected to result in or form the basis for any such action, suit, arbitration or other proceeding. Neither EG nor EG I is in default with respect to any order, writ, judgment, injunction, decree, determination or award of any court or any governmental agency or instrumentality or arbitration authority.


Section 3.15  

ERISA.  Each of EG and EG I is in compliance in all material respects with all currently applicable provisions of ERISA, except where a failure to so comply would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; no unwaivable “reportable event” (as defined in ERISA) has occurred with respect to any “pension plan” (as defined in ERISA) for which either would have any respective liability; neither EG nor EG I has incurred and does not expect to incur any material liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any “pension plan” or (ii) Sections 412 or 4971 of the Code; and each “pension plan” for which they would have any liability that is intended to be qualified under Section 401(a) of the Code is so qualified in all material respects and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification.



13




 



Section 3.16

Environmental Matters .  EG and EG I are each in compliance with all environmental Laws relating to their respective properties or facilities (including real property, especially business premises, buildings, land property, heritable building rights, etc.) used, leased or occupied by them.


ARTICLE IV

SPECIAL COVENANTS


Section 4.1

Availability of Rule 144 . The Parent stockholders holding “restricted securities”, as that term is defined in Rule 144 of the Securities Act will remain as “restricted securities” after the Closing Date.  Parent is under no obligation to register such shares under the Securities Act, or otherwise.  The stockholders of Parent holding restricted securities of Parent as of the date of this Agreement and their respective heirs, administrators, personal representatives, successors and assigns, are intended third party beneficiaries of the provisions set forth herein.  The covenants set forth in this Section 4.1 shall survive the Closing Date.



Section 4.2

Conduct of Business by Parent Pending the Closing Date.  Prior to the Closing Date, unless EG and EG I shall otherwise agree in writing or as otherwise contemplated by this Agreement:


(a)

Parent shall not (i) directly or indirectly redeem, purchase or otherwise acquire or agree to redeem, purchase or otherwise acquire any shares of its capital stock entering into any agreements or contracts; (ii) amend its Certificate of Incorporation or By-laws except to effectuate the transactions contemplated herein; (iii) split, combine or reclassify outstanding common stock or declare, set aside or pay any dividend payable in cash, stock or property or make any distribution with respect to any such stock; (iv) liquidate, dissolve or otherwise wind up their affairs;  (v) avail itself of the protection of bankruptcy laws or other laws for the protection of creditors; (vi) change or otherwise alter their respective principal business, exit their current lines of business or enter into unrelated lines of business; (vii) change their respective current accountants or auditors;


(b)

Parent shall not (i) issue or agree to issue any additional shares of, or options, warrants or rights of any kind to acquire any shares of, common stock; (ii) acquire or dispose of any fixed assets or acquire or dispose of any other substantial assets other than in the ordinary course of business; (iii) incur additional indebtedness or undertake any other liabilities without the prior written consent of EG and EG I, such consent not to be unreasonably withheld; (iv) grant liens, or security interests or enter into any other transaction other than in the ordinary course of business; (v) enter into any contract, agreement, commitment or arrangement with respect to any of the foregoing or (vi) except as contemplated by this Agreement, enter into any contract, agreement, commitment or arrangement to dissolve, merge, consolidate or enter into any other material business combination;


(c)

Parent Entities shall use their best efforts to preserve intact their respective business organizations, to keep available the service of their respective present officers and key employees, and to preserve the good will of those with which they have business relationships;


(d)

Parent shall not, nor will Parent authorize any director or authorize or permit any officer or employee or any attorney, accountant or other representative retained by it to make, solicit, encourage any inquiries with respect to, or engage in any negotiations concerning, any Acquisition Proposal (as defined below for purposes of this paragraph). Parent will promptly advise EG and EG I orally and in writing of any such inquiries or proposals (or requests for information) and the substance thereof. As used



14




 


in this paragraph, “ Acquisition Proposal ” shall mean any proposal for a merger or other business combination involving either EG or EG I or for the acquisition of a substantial equity interest in it or any material assets of it other than as contemplated by this Agreement. Parent will immediately cease and cause to be terminated any existing activities, discussions or negotiations with any person conducted heretofore with respect to any of the foregoing; and


(e)

Parent shall not (i) enter into any new employment agreements or arrangements with any of its officers or employees; (ii) grant any increases in the compensation or benefits of its officers and employees; (iii) amend any employee benefit plan or arrangement or (iv) enter into or be a party to any transaction with any director, officer or employee, or any "associate" as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended.


Section 4.3. Following the date of execution of this Agreement, EG and EG I shall pay all expenses of Parent for the filing of the Parent’s periodic reports with the Securities and Exchange Commission

 

ARTICLE V

LEGAL OBLIGATIONS


Section 5.1.

 Legal Conditions to EG Merger.   Except as otherwise provided herein, EG and Parent will, and will cause their respective subsidiaries to, take all reasonable actions necessary to comply promptly with all legal requirements that may be imposed on such party with respect to the EG Merger and will promptly cooperate with and furnish information to each other in connection with any such requirements imposed upon any of them or any of their subsidiaries in connection with the Merger.  Each of EG and Parent will, and will cause their respective subsidiaries to, take all actions reasonably necessary to obtain (and will cooperate with each other in obtaining) any consent, acquiescence, authorization, order or approval of, or any exemption or non-opposition by, any Governmental Entity or court required to be obtained or made by EG or Parent or any of their subsidiaries in connection with the EG Merger or the taking of any action contemplated thereby or by this Agreement.  


Section 5.2.

 Legal Conditions to EG I Merger.   Except as otherwise provided herein, each of EG I and Parent will, and will cause their respective subsidiaries to, take all reasonable actions necessary to comply promptly with all legal requirements that may be imposed on such party with respect to the EG I Merger and will promptly cooperate with and furnish information to each other in connection with any such requirements imposed upon any of them or any of their subsidiaries in connection with the Merger.  Each of EG I and Parent will, and will cause their respective subsidiaries to, take all actions reasonably necessary to obtain (and will cooperate with each other in obtaining) any consent, acquiescence, authorization, order or approval of, or any exemption or non-opposition by, any Governmental Entity or court required to be obtained or made by EG I, Parent or any of their subsidiaries in connection with the EG I Merger or the taking of any action contemplated thereby or by this Agreement.  


Section 5.3

Agreement to Defend .  In the event any claim, action, suit, investigation or other proceed­ing by any governmental body or other person or other legal or administrative proceeding is com­menced that questions the validity or legality of the transactions contemplated hereby or seeks damages in connection therewith, the parties hereto agree to cooperate and use their reasonable efforts to defend themselves against and respond thereto.




15




 


Section 5.4.

Public Announcements, Regulation FD and Other Obligations.  


(a)

On or after the Closing Date, Parent, EG and EG I will agree with each other with respect to the contents thereof before issuing any press release or otherwise making any public statements with respect to the transactions contemplated by this Agreement, including those as may be required by SEC rules and regulations, applicable law or by obligations pursuant to any listing agreement with any national securities exchange or transaction reporting system.  After the Closing Date, Parent may make public statements without the consent of EG and EG I if required by applicable law.  


(b)

Any information concerning EG and EG I disclosed to Parent or its subsidiaries or their respective affiliates or representatives or any information concerning Parent or its subsidiaries or their respective affiliates or representatives disclosed to EG and EG I, which has not been publicly disclosed, shall be kept strictly confidential by the parties hereto and shall not be disclosed or used by the recipients until publicly disclosed by the party to which such information relates; provided , however , that the foregoing provision shall not prohibit disclosures by any party of information that (i) was in the possession of a party prior to the date hereof, provided that such information is not known by such party to be subject to a confidentiality agreement, (ii) is or becomes generally available to the public other than as a result of a disclosure by a party in violation of this Section 5.4 or (iii) a party is required to disclose by law, including in connection with a proceeding or in connection with the payment of taxes.  Each party hereto hereby agrees that no public announcements concerning the terms of this Agreement or the transactions contemplated thereunder shall be made without the mutual consent of the parties, not to be unreasonably withheld.  Notwithstanding the foregoing, Parent shall be entitled to issue a press release announcing the execution of this Agreement and the transactions contemplated hereunder once the Closing occurs.  


Section 5.5.

Other Actions; Maintenance of Business .  Except as contemplated by this Agreement, neither Parent nor EG or EG I shall, and shall not permit any of its subsidiaries to, take or agree or commit to take any action that is likely to result in any of its respective representations or warranties in this document being untrue or in any of the conditions to the Mergers set forth in Article VI not being satisfied.  Prior to the Closing Date, EG and EG I will each use commercially reasonable efforts to maintain their respective business in accordance with customary practices and otherwise to conduct their respective business in the ordinary course in the manner in which it has heretofore been conducted and to preserve their respective business relationships with customers and suppliers.


Section 5.6.

Reservation of Common Shares . Parent shall at all times reserve and keep available, free from preemptive rights, out of the aggregate of its respective authorized but unissued shares of Parent Common Stock for the purpose of enabling it to satisfy any obligation to issue shares of Parent Common Stock.  Parent or, if appointed, any transfer agent for the Parent Common Stock (the “ Transfer Agent ”), will be irrevocably authorized and directed at all times to reserve such number of authorized shares as shall be required for such purpose.  Parent shall keep a copy of this Agreement on file with any such Transfer Agent.  Parent will supply any such Transfer Agent with duly executed certificates for such purposes.  Parent will furnish any such Transfer Agent a notice of all adjustments and certificates related thereto.  Parent covenants that all Parent Common Stock will be validly authorized an issued, fully paid, nonassessable, free of preemptive rights and free from all taxes, liens, charges and security interests with respect to the issue thereof.


Section 5.7. Blue Sky Laws .  Parent shall take any action (other than qualifying to do business in any jurisdiction in which it is not now so qualified) required to be taken under any applicable state securities laws in connection with the issuance of the Parent Common Stock in connection with this Agreement. All fees, costs and expenses incurred for such filing shall be paid by Parent .



16




 


Section 5.8.

Regulatory Matters.   Parent, EG, andEG I shall cooperate it providing each other information necessary for compliance with all regulatory matters.


ARTICLE VI

CLOSING DOCUMENTS AND CONDITIONS


Section 6.1.   Conditions to Each Party’s Obligations .  The obligations of each party to consummate the Mergers and other transactions described herein shall be subject to the satisfaction or waiver (where permissible), at or prior to the Closing, of the following conditions:


(a)

Requisite Regulatory Approvals and Consents. All authorizations, approvals and permits required to be obtained from or made with any Governmental Entity in order to consummate the transactions contemplated by this Agreement, and all consents from third persons that are required in connection with the transactions contemplated by this Agreement, shall have been obtained or made.


(b)

No Law. No Governmental Entity shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) or order that is then in effect and has the effect of making the Merger illegal or otherwise preventing or prohibiting consummation of the Merger.

 

(c)

Registration or Exemption.  All necessary permits and authorizations under state securities or “blue sky” laws, the Securities Act and the Exchange Act relating to the issuance and trading of the Parent Common Stock to be issued in the Merger shall have been obtained and shall be in effect.  It shall be Parent’s obligation to obtain such permits and authorizations.


(d)

EG Stockholder Approval.  This Agreement and the EG Merger contemplated thereby shall have been approved and adopted by the affirmative vote of the holders of a majority of the EG Shares entitled to vote thereon.


(e)

EG I Member Approval.  This Agreement and the EG I Merger contemplated thereby shall have been approved and adopted by the affirmative vote of the holders of a majority of the outstanding EG I Membership Interests entitled to vote thereon.


(f)

Parent Stockholder Approval.  If required by applicable law, this Agreement and the Mergers contemplated thereby shall have been approved and adopted by the affirmative vote of the holders of a majority of the outstanding Parent Common Stock entitled to vote thereon.


(g)

Sub Stockholder Approval.  If required by applicable law, this Agreement and the EG Merger contemplated thereby shall have been approved and adopted by the affirmative vote of the holders of a majority of the outstanding shares of common stock of Sub entitled to vote thereon.


(h)

Sub LLC Member Approval.  If required by applicable law, this Agreement and the EG I Merger contemplated thereby shall have been approved and adopted by the affirmative vote of the holders of a majority of the outstanding membership interests of Sub LLC entitled to vote thereon.



(i)

No Appraisal Rights.  Holders of the EG Shares and EG I Membership Interests shall not be entitled to dissenters’ or appraisal rights under DGCL or CRS with respect to the Mergers.


(j)

Reverse Split.  Parent shall have effected a reverse split of the Parent Common Stock in a ratio of one share for every 60.8826565 shares outstanding.




17




 


Section 6.2

Conditions to Obligation of Parent and its Subsidiaries .  The obligations of Parent and its subsidiaries to consummate the Mergers are subject to the satisfaction or waiver (where permissible) of the following additional conditions:

(a)

Representations and Warranties. Each of the representations and warranties of Parent, EG and EG I set forth in this Agreement shall be true and correct in all material respects as of the Closing as though made as of the Closing, except (i) to the extent that such representations and warranties refer specifically to an earlier date, in which case such representations and warranties shall have been true and correct as of such earlier date, and (ii) this condition shall be deemed satisfied unless the incorrectness of such representations and warranties would, in the aggregate, reasonably be expected to result in a Material Adverse Effect.


(b)

Agreements and Covenants.  EG and EG I shall each have performed in all material respects all of their respective obligations and complied with all of their respective agreements and covenants to be performed or complied with by them under this Agreement at or prior to the Closing.


(c)

EG Officer Certificate.  EG shall have delivered to Parent a certificate, dated the Closing Date, signed by the chief executive officer and chief financial officer of EG, certifying in such capacity as to the satisfaction of the conditions specified in Sections 6.2(a) , 6.2(b) , 6.2(g) and 6.2(h) .


(d)

EG I Officer Certificate.  EG I shall have delivered to Parent a certificate, dated the Closing Date, signed by the President and Treasurer of EG I, certifying in such capacity as to the satisfaction of the conditions specified in Sections 6.2(a) , 6.2(b) , 6.2(g) and 6.2(h) .


(e)

EG Secretary’s Certificate.  EG shall have delivered to Parent a true copy of the resolutions of EG authorizing the execution of this Agreement and the consummation of the EG Merger and transactions contemplated herein, signed by all of members of the Board of Directors of EG and certified by the secretary or similar officer.


(f)

EG I Secretary’s Certificate.  EG I shall each have delivered to Parent a true copy of the resolutions of EG I authorizing the execution of this Agreement and the consummation of the EG I Merger and transactions contemplated herein, signed by all of members of the Board of Managers certified by the secretary or similar officer.


(g)     

Each of the  EG Shareholders and EG I Members  shall have delivered certificates and attached powers of attorney for their respective shares in EG and EG I to the Parent, as set forth above.


 (h)

Material Adverse Effect.  No Material Adverse Effect shall have occurred since the date of this Agreement with respect to Parent, EG or EG I.


Section 6.3.

Conditions to Obligation of EG .  The obligations of EG to consummate the EG Merger are subject to the satisfaction or waiver (where permissible) of the following additional conditions:


(a)  Representations and Warranties. Each of the representations and warranties of Parent and its subsidiaries set forth in this Agreement shall be true and correct as of the date of this Agreement and as of the Closing as though made as of the Closing, except (i) to the extent that such representations and warranties refer specifically to an earlier date, in which case such representations and warranties shall have been true and correct as of such earlier date, and (ii) this condition shall be deemed satisfied unless the incorrectness of such representations and warranties would, in the aggregate, reasonably be expected to result in a Material Adverse Effect.  



18




 


(b)

Agreements and Covenants.  Parent shall have performed in all material respects all of its obligations and complied with all of their respective agreements and covenants to be performed or complied with by them under this Agreement at or prior to the Closing.


(c)

Parent Officer Certificate.  Parent shall have delivered to EG a certificate, dated the Closing Date, signed by the chief executive officer or chief financial officer of Parent, certifying in such capacity as to the satisfaction of the conditions specified in Sections 6.3(a) , 6.3(b) , 6.3(e) and 6.3(f) .


(d)

Parent Secretary’s Certificate. Parent shall have delivered to EG a true copy of the resolutions of Parent authorizing the execution of this Agreement and the consummation of the EG Merger and transactions contemplated herein, certified by the Secretary of Parent or similar officer.    


(e)

Sub Secretary’s Certificate. Sub shall have delivered to EG a true copy of the resolutions of Sub authorizing the execution of this Agreement and the consummation of the EG Merger and transactions contemplated herein, certified by the Secretary of Sub or similar officer.    


(f)

Parent Entities Material Adverse Effect.  No Material Adverse Effect shall have occurred since the date of this Agreement with respect to the Parent Entities.


(g)

Election and Resignation of Directors and Officers.  Evidence of the election or appointment, as applicable, of Steve B. Warnecke, Virginia Orndorff and Mark Boggess.


(h)

Immediately after the Closing, Parent will have 5,881,898 shares of its common stock issued and outstanding.


(i)

EG shall have conducted to their reasonable satisfaction a due diligence investigation of the business and operations of the Parent Entities.


(j)

As of the Closing, the Parent Entities shall have no assets or liabilities, it being agreed that all liabilities of the Parent Entities as shown in the SEC Reports or otherwise shall have been paid in full as of the Closing, as evidenced by written documentation reasonably satisfactory to each EG and EG I.  EG shall have been furnished with a certificate dated the Closing Date and signed by the executive officers, of each Parent Entities certifying satisfaction of all liabilities of the Parent Entities as of the Closing Date and that each of the representations and warranties of the Parent Entities contained in this Agreement are true and correct on and as of the Closing Date to the satisfaction of each EG


Section 6.4.

Conditions to Obligation of EG I .  The obligations of EG I to consummate the EG I Merger are subject to the satisfaction or waiver (where permissible) of the following additional conditions:


(a)  Representations and Warranties. Each of the representations and warranties of Parent and its subsidiaries set forth in this Agreement shall be true and correct as of the date of this Agreement and as of the Closing as though made as of the Closing, except (i) to the extent that such representations and warranties refer specifically to an earlier date, in which case such representations and warranties shall have been true and correct as of such earlier date, and (ii) this condition shall be deemed satisfied unless the incorrectness of such representations and warranties would, in the aggregate, reasonably be expected to result in a Material Adverse Effect.  


(b)

Agreements and Covenants.  Parent Entities shall have performed in all material respects all of their respective obligations and complied with all of their respective agreements and covenants to be performed or complied with by them under this Agreement at or prior to the Closing.



19




 


(c)

Parent Officer Certificate.  Parent shall have delivered to EG I a certificate, dated the Closing Date, signed by the chief executive officer or chief financial officer of Parent, certifying in such capacity as to the satisfaction of the conditions specified in Sections 6.4(a) , 6.4(b) , 6.4(f) and 6.4(g) .


(d)

Parent Secretary’s Certificate. Parent shall have delivered to EG I a true copy of the resolutions of Parent authorizing the execution of this Agreement and the consummation of the EG I Merger and transactions contemplated herein, certified by the Secretary of Parent or similar officer.    


(e)

Certificate of Sub LLC Managing Member. Sub LLC shall have delivered to EG I a true copy of the resolutions of Sub LLC authorizing the execution of this Agreement and the consummation of the EG I Merger and transactions contemplated herein, certified by the managing member of Sub LLC or executive officer.    


(f)

Parent Entities Material Adverse Effect.  No Material Adverse Effect shall have occurred since the date of this Agreement with respect to the Parent Entities.


(g)

Election and Resignation of Directors and Officers.  Evidence of the election or appointment, as applicable, of Steve B. Warnecke, Virginia Orndorff and Mark Boggess.


(h)

Immediately after the Closing, Parent will have 5,881,898 shares of its common stock issued and outstanding.


(i)

 EG I shall have conducted to their reasonable satisfaction a due diligence investigation of the business and operations of the Parent Entities.


(j)

As of the Closing, the Parent Entities shall have no assets or liabilities, it being agreed that (i) all liabilities of the Company as shown in the SEC Reports or otherwise shall have been paid in full as of the Closing, as evidenced by written documentation reasonably satisfactory to EG I and (ii) any assets of the Parent other than cash shall, as of the Closing, been transferred or assigned by the Company, as evidenced by written documentation reasonably satisfactory to EG I.  EG I shall have been furnished with a certificate dated the Closing Date and signed by Parent’s executive officers of the Parent, certifying satisfaction of all liabilities of the Company as of the Closing Date and that each of the representations and warranties of the Company contained in this Agreement are true and correct on and as of the Closing Date to the satisfaction of EG I.


Section 6.5

Indemnification.


(a)

EG Indemnification of Parent Entities.  Subject to the limitations set forth herein, EG shall indemnify and hold Parent Entities and their respective affiliates, directors, officers, shareholders, representatives, employees and agents, as applicable, harmless from and against any and all liabilities, obligations, claims, contingencies, damages, costs and expenses, including all court costs, litigation expenses and reasonable attorneys’ fees, (individually a “ Loss ,” and collectively, “ Losses ”), that Parent Entities and their affiliates, directors, officers, shareholders, representatives, employees and agents, as applicable, may suffer or incur as a result of or relating to the breach of any representation, covenant or warranty made by EG under this Agreement or by EG in any EG documents or other instrument delivered pursuant hereto or thereto (other than covenants or agreements to be performed after the Closing); and


(b)

EG I Indemnification of Parent Entities.  Subject to the limitations set forth herein, EG I will indemnify and hold Parent Entities and their respective affiliates, directors, officers, shareholders, representatives, employees and agents, as applicable, harmless from and against any and all Losses, that Parent Entities  and their respective affiliates, directors, officers, shareholders, representatives, employees



20




 


and agents, as applicable, may suffer or incur as a result of or relating to the breach of any representation, covenant or warranty made by EG I under this Agreement or by EG I in any EG I documents or other instrument delivered pursuant hereto or thereto(other than covenants or agreements to be performed after the Closing); and


(b)

Parent Entities Indemnification of EG, EG I, EG Shareholders and EG I Members. Parent Entities, jointly and severally, agree to indemnify each EG, EG I, the EG Shareholders and EG I Members and hold harmless from and against and with respect to, and shall reimburse each EG, EG I, the EG Shareholders and EG I Members for any and all Losses resulting from the breach of any representation, covenant or warranty made by Parent Entities in this Agreement or any other document delivered pursuant hereto or thereto by such parties (other than covenants or agreements to be performed after the Closing).


ARTICLE VII

TERMINATION

7.1

Termination.  This Agreement may be terminated at any time prior to the Closing Date:

(a)

by either the Board of Directors of each EG, Parent, Sub or the Board of Managers of EG I or managing member of Sub LLC.

7.2

Effect of Termination.  In the event of termination of this Agreement by either EG, EG I or Parent Entities as provided in Section 7.1, this Agreement shall forthwith become void and have no effect, and none of EG, EG I,  Parent Entities, any of their respective subsidiaries or any of the officers or directors of any of them shall have any liability of any nature whatsoever under this Agreement, or in connection with the transactions contemplated by this Agreement, except that (i) Sections 7.2, 8.2, 8.3, 8.4 and 8.12 shall survive any termination of this Agreement and (ii) notwithstanding anything to the contrary contained in this Agreement, neither EG, EG I nor Parent Entities shall be relieved or released from any liabilities arising out of its willful breach of any provision of this Agreement shall be cancelled so that, as of the date of termination,  the Parent Entities shall only have liabilities that were incurred following the date hereof and approved in accordance with Section 4.2.  



ARTICLE VIII

MISCELLANEOUS


Section 8.1

Brokers and Finders .  On the Closing Date, each party hereto hereby represents and warrants that it is under no obligation, express or implied, to pay certain finders in connection with the bringing of the parties together in the negotiation, execution, or consummation of this Agreement.


Section 8.2

Law, Forum and Jurisdiction .  This Agreement shall be construed and interpreted in accordance with the laws of the State of Delaware, United States of America, without giving effect to such state’s principles of conflicts of laws.  All disputes, controversies or claims arising out of or relating to this Agreement shall be brought in Federal Court of the District of Colorado or in a state court located in Denver, Colorado. The parties hereby irrevocably waive any objection to jurisdiction and venue or any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The parties agree to submit to the in personam jurisdiction of such courts.  The prevailing party in any such dispute shall be entitled to recover from the other party its reasonable attorneys’ fees, costs and expenses.




21




 


Section 8.3

Notices .  Any notices or other communications required or permitted hereunder shall be sufficiently given if personally delivered to it or sent by registered mail or certified mail, postage prepaid, or by prepaid telegram addressed as follows:


If to EG:


Steve B. Warnecke, CEO

1026 Anaconda Drive

Castle Rock, CO  80108

warnecke@comcast.net


If to EG I:


Steve B. Warnecke

President of Sixty-Five Roses Ranch, Inc., Managing Member

1026 Anaconda Drive

Castle Rock, CO  80108

warnecke@comcast.net


If to Parent


Steve B. Warnecke

Fona, Inc.

1026 Anaconda Drive

Castle Rock, CO  80108

With a copy to (which shall not constitute notice):


Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas, 11 th Floor

New York, NY 10105

Attn: Barry I. Grossman, Esq.


If to Sub:


Steve B. Warnecke

1026 Anaconda Drive

Castle Rock, CO  80108

warnecke@comcast.net


If to Sub LLC:


Steve B. Warnecke

1026 Anaconda Drive

Castle Rock, CO  80108

warnecke@comcast.net


or such other addresses as shall be furnished in writing by any party in the manner for giving notices hereunder, and any such notice or communication shall be deemed to have been given as of the date so delivered, mailed or telegraphed.




22




 


Section 8.4

Entire Agreement.   This Agreement represents the entire agreement between the parties relating to the subject matter hereof.  This Agreement alone fully and completely expresses the agreement of the parties relating to the subject matter hereof.  There are no other courses of dealing, understanding, agreements, representations or warranties, written or oral, except as set forth herein.  This Agreement may not be amended or modified, except by a written agreement signed by all parties hereto.  


Section 8.5

Counterparts .  This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which taken together shall be but a single instrument.


Section 8.6

 Amendment or Waiver.  Every right and remedy provided herein shall be cumulative with every other right and remedy, whether conferred herein, at law, or in equity, and may be enforced concurrently herewith, and no waiver by any party of the performance of any obligation by the other shall be construed as a waiver of the same or any other default then, theretofore, or thereafter occurring or existing.  At any time prior to the Closing Date, this Agreement may be amended by a writing signed by all parties hereto, with respect to any of the terms contained herein, and any term or condition of this Agreement may be waived or the time for performance hereof may be extended by a writing signed by the party or parties for whose benefit the provision is intended.


Section 8.7

Expenses .  

EG and EG I shall bear all expenses in connection with this Agreement and the transactions contemplated thereby in accordance with Section 4.2 of this Agreement.  


Section 8.8

Headings; Context .  The headings of the sections and paragraphs contained in this Agreement are for convenience of reference only and do not form a part hereof and in no way modify, interpret or construe the meaning of this Agreement.


Section 8.9

Benefit .  Except as set forth in Section 4.1, this Agreement shall be binding upon and shall inure only to the benefit of the parties hereto, and their permitted assigns hereunder.  This Agreement shall not be assigned by any party without the prior written consent of the other party.  


Section 8.10

Severability .  In the event that any particular provision or provisions of this Agreement or the other agreements contained herein shall for any reason hereafter be determined to be unenforceable, or in violation of any law, governmental order or regulation, such unenforceability or violation shall not affect the remaining provisions of such agreements, which shall continue in full force and effect and be binding upon the respective parties hereto.


Section 8.11

Execution Knowing and Voluntary .  In executing this Agreement, the parties severally acknowledge and represent that each:  (a) has fully read and considered this Agreement; (b) has been or has had the opportunity to be fully apprized by its attorneys of the legal effect and meaning of this document and all terms and conditions hereof; (c) is executing this Agreement voluntarily, free from any influence, coercion or duress of any kind. The exchange of copies of this Agreement and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Agreement.


Section 8.12

Survival of Representations, Warranties and Agreements .  All of the representations, warranties and agreements in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Closing for a period of  eighteen (18) months from the Closing Date, except for those related to taxes, which shall survive as long as the applicable statute of limitations.



[Remainder of Page Intentionally Left Blank]




23






[Signature Page to Share Exchange Agreement]


IN WITNESS WHEREOF , the corporate parties hereto have caused this Agreement to be executed by their respective officers, hereunto duly authorized, and entered into as of the date first above written.


FONA, INC.


 

/s/ Steve B. Warnecke

By: Steve B. Warnecke

Chief Executive Officer

 

FONA MERGER SUB, INC.


 

Steve B. Warnecke

By: Steve B. Warnecke

Chief Executive Officer

 

FONA MERGER SUB, LLC


 

By:

Steve B. Warnecke

Name:

Steve B. Warnecke

Title:

Chief Executive Officer

 


EVOLUTIONARY GENOMICS, INC.

 

By:

Steve B. Warnecke

Name:

Steve B. Warnecke

Title:

Chief Executive Officer

 

 


EG I, LLC

 

By:

Steve B. Warnecke

Name:

Steve B. Warnecke

Title:

President of Sixty-Five Roses Ranch, Inc., Managing Member

 

 










EXHIBIT A  


PRO FORMA CAPITALIZATION TABLE


[FNAM_EX10Z1002.GIF]




 






EXHIBIT 31.1

CERTIFICATION

I, Steve Warnecke, certify that:

1. I have reviewed this annual report on Form 10-K of Fona, Inc.

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting, to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting .

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information ; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

March 4, 2015

 

 

BY:  

/s/ Steve Warnecke

 

Steve Warnecke

 

Chief Executive Officer

 

(principal executive officer)




EXHIBIT 31.2

CERTIFICATIONS

I, Steve Warnecke, certify that:

1. I have reviewed this annual report on Form 10-K of Fona, Inc.

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting, to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting .

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information ; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

March 4, 2015

 

 

BY:  

/s/ Steve Warnecke

 

Steve Warnecke

 

Chief Financial Officer

 

(principal financial officer)




EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Fona, Inc. (the "Company") on Form 10-Q for the year ended December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steve B Warnecke, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




BY:  

/s/ Steve B Warnecke

 

Steve B Warnecke

 

Chief Executive Officer and Chief Financial Officer

 

(principal executive and financial officer)

 

March 4, 2015